{
  "meta": {
    "id": "test6",
    "title": "Pharmacology E&D - Mission 1.5, Lap 2 - 12-06-2024 - 2024-06-11",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which among the following drugs doesn\u2019t require any renal dose modification in the patients with chronic kidney disease? (Fmge June 2021)",
      "options": [
        {
          "label": "A",
          "text": "Saxagliptin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Linagliptin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Repaglinide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Glyburide",
          "correct": false
        }
      ],
      "correct_answer": "B. Linagliptin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Linagliptin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For patients with chronic kidney disease, especially those at different stages of renal impairment, choosing antidiabetic medications that do not require renal adjustments can simplify management. Linagliptin stands out among the options given for its liver metabolism and minimal renal elimination, offering a safer profile for CKD patients without the need for dose modifications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f14e9afd",
      "audio": ""
    },
    {
      "text": "A female patient presented with greenish vaginal discharge and pruritus. Clue cells were present. What is the drug of choice for this condition? (FMGE DECEMBER 2021)",
      "options": [
        {
          "label": "A",
          "text": "Doxycycline",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metronidazole",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ceftriaxone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fluconazole",
          "correct": false
        }
      ],
      "correct_answer": "B. Metronidazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Metronidazole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Metronidazole is the drug of choice for treating Bacterial Vaginosis due to its effectiveness against the anaerobic bacteria commonly associated with the condition. It can be administered either orally or as a topical gel or cream. In cases where metronidazole cannot be used, clindamycin is a suitable alternative. This knowledge is crucial for appropriate clinical management to relieve symptoms and prevent potential complications related to BV.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "afa30a40",
      "audio": ""
    },
    {
      "text": "Which of the following is the shortest-acting cardioselective beta blocker? (Fmge June 2022)",
      "options": [
        {
          "label": "A",
          "text": "Nadolol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propranolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Esmolol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Atenolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Esmolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Esmolol</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Esmolol is the shortest-acting cardioselective beta blocker due to its rapid metabolism by plasma cholinesterase. It is particularly useful for managing acute conditions such as intraoperative tachycardia, supraventricular tachycardia, and hypertensive emergencies where rapid onset and quick offset of action are desired.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d7606fc8",
      "audio": ""
    },
    {
      "text": "Identify the type of inhibition given in the graph? (Fmge Jan 2023)",
      "options": [
        {
          "label": "A",
          "text": "Competitive",
          "correct": false
        },
        {
          "label": "B",
          "text": "Un-competitive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Non-competitive",
          "correct": true
        },
        {
          "label": "D",
          "text": "Allosteric",
          "correct": false
        }
      ],
      "correct_answer": "C. Non-competitive",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/2_h99LToF.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/3_UmZzKsx.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Non-competitive</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The given graph illustrates non-competitive inhibition, where the inhibitor binds to an allosteric site, causing a decrease in Vmax while Km remains constant. This type of inhibition affects the enzyme's activity without altering the substrate's binding affinity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "79c5deba",
      "audio": ""
    },
    {
      "text": "A young male, diagnosed with thalassemia, is experiencing iron overload due to repeated blood transfusions over the years. Which of the following medications is the most appropriate for managing his chronic iron overload? (Fmge July 2023)",
      "options": [
        {
          "label": "A",
          "text": "EDTA",
          "correct": false
        },
        {
          "label": "B",
          "text": "Desferrioxamine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Deferiprone",
          "correct": true
        },
        {
          "label": "D",
          "text": "Penicillamine",
          "correct": false
        }
      ],
      "correct_answer": "C. Deferiprone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Deferiprone</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Deferiprone is an effective oral iron chelator used to manage chronic iron overload in thalassemia patients, making it a convenient and appropriate choice for reducing excess iron levels resulting from repeated blood transfusions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22b57e55",
      "audio": ""
    },
    {
      "text": "What is the mechanism of action of bedaquiline, a new drug used in the treatment of multidrug-resistant tuberculosis (MDR-TB)? (FMGE July 2023)",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of ATP synthesis by mycobacteria",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inhibition of mycolic acid synthesis in mycobacteria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inhibition of RNA polymerase in mycobacteria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhibition of protein synthesis in mycobacteria",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of ATP synthesis by mycobacteria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Inhibition of ATP synthesis by mycobacteria</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Bedaquiline treats multidrug-resistant tuberculosis by inhibiting ATP synthase in mycobacteria, thereby disrupting the production of ATP and hindering the bacteria's growth and survival.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d82b59db",
      "audio": ""
    },
    {
      "text": "A 55-year-old female with a history of chronic stable angina is seen in the outpatient department. She is already taking aspirin and statins, but continues to experience occasional chest pain during exertion. Which of the following would be the most appropriate choice for prophylactic treatment of her angina? (Fmge July 2023)",
      "options": [
        {
          "label": "A",
          "text": "Sublingual nitroglycerine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous nitroglycerine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral nitroglycerine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intratracheal nitroglycerine",
          "correct": false
        }
      ],
      "correct_answer": "C. Oral nitroglycerine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Oral nitroglycerine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Oral nitroglycerine, a long-acting nitrate preparation, is the most appropriate choice for the prophylactic treatment of chronic stable angina to prevent angina episodes during exertion.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "38c8be91",
      "audio": ""
    },
    {
      "text": "A 2-month pregnant female presented with Plasmodium vivax malaria. Which of the following is the appropriate treatment for this patient? (Fmge Jan 2024)",
      "options": [
        {
          "label": "A",
          "text": "Chloroquine plus primaquine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Quinine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Artemisinin based combination therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Doxycycline",
          "correct": false
        }
      ],
      "correct_answer": "B. Quinine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Quinine</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Quinine is often used as a treatment for malaria during pregnancy, especially if other options are not available or suitable. However, it is usually more associated with the treatment of Plasmodium falciparum rather than Plasmodium vivax.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6c506820",
      "audio": ""
    },
    {
      "text": "A patient was given digoxin. He started having side effects like nausea and vomiting. The serum concentration of digoxin was 4 mg/dL. The plasma therapeutic range is 1 mg/dL. If the half-life of digoxin is 40 hours, how long one should wait before resuming the treatment? (NEET PG 2023)",
      "options": [
        {
          "label": "A",
          "text": "40 hours",
          "correct": false
        },
        {
          "label": "B",
          "text": "80 hours",
          "correct": true
        },
        {
          "label": "C",
          "text": "120 hours",
          "correct": false
        },
        {
          "label": "D",
          "text": "140-180 hours",
          "correct": false
        }
      ],
      "correct_answer": "B. 80 hours",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 80 hours</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For a patient experiencing side effects from digoxin with a serum concentration of 4 mg/dL, wait 80 hours (two half-lives) for the concentration to decrease to the therapeutic range before resuming treatment.</li><li>\u27a4 80 hours</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "928ed148",
      "audio": ""
    },
    {
      "text": "Theophylline was prescribed to a male patient with chronic obstructive pulmonary disease (COPD). The next day, he noticed that his urine output had increased. Which of the following receptors is responsible for the drug's action? (NEET PG 2022)",
      "options": [
        {
          "label": "A",
          "text": "Interleukin-10",
          "correct": false
        },
        {
          "label": "B",
          "text": "Histone deacetylase",
          "correct": false
        },
        {
          "label": "C",
          "text": "Adenosine A1",
          "correct": true
        },
        {
          "label": "D",
          "text": "Beta 2 adrenergic receptors",
          "correct": false
        }
      ],
      "correct_answer": "C. Adenosine A1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Adenosine A1</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Theophylline increases urine output by antagonizing adenosine A1 receptors, leading to decreased water reabsorption in the renal tubules and resulting in diuresis.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8159abea",
      "audio": ""
    },
    {
      "text": "A middle-aged male patient presents with chin protrusion, excessive sweating, impaired glucose tolerance, and hand and foot enlargement. What is a growth hormone receptor antagonist used to treat this condition? (NEET PG 2022)",
      "options": [
        {
          "label": "A",
          "text": "Octreotide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pegvisomant",
          "correct": true
        },
        {
          "label": "C",
          "text": "Cabergoline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Olcegepant",
          "correct": false
        }
      ],
      "correct_answer": "B. Pegvisomant",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Pegvisomant</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone at the receptor level, thereby reducing the symptoms associated with elevated growth hormone levels.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7af2b73",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient with a history of depression was started on amitriptyline, a tricyclic antidepressant (TCA). The patient was later found unconscious at home and brought to the emergency department. On examination, the patient shows signs of arrhythmias, confusion, and pupillary dilation. Which of the following does NOT suggest TCA poisoning?",
      "options": [
        {
          "label": "A",
          "text": "Arrhythmias",
          "correct": false
        },
        {
          "label": "B",
          "text": "Confusion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hypothermia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pupillary dilation",
          "correct": false
        }
      ],
      "correct_answer": "C. Hypothermia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Hypothermia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hypothermia is not a typical feature of tricyclic antidepressant (TCA) poisoning, whereas arrhythmias, confusion, and pupillary dilation are common clinical manifestations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1fc71788",
      "audio": ""
    },
    {
      "text": "A patient with a history of diabetes mellitus presents with heart failure characterized by a reduced ejection fraction and low urine output. Which of the following anti-diabetic medications has been recently approved for the treatment of heart failure with reduced ejection fraction, and may also improve diuresis?",
      "options": [
        {
          "label": "A",
          "text": "Empagliflozin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Linagliptin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rosiglitazone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Insulin degludec",
          "correct": false
        }
      ],
      "correct_answer": "A. Empagliflozin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Empagliflozin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Empagliflozin, an SGLT2 inhibitor, is approved for the treatment of heart failure with reduced ejection fraction and provides cardiovascular benefits, including increased diuresis, which can help manage fluid overload in heart failure patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "becd7c7f",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman with a history of chronic urticaria comes to the clinic for a consultation regarding her medication regimen. She reports no significant relief from her symptoms despite adherence to her prescribed medications. The physician suspects that genetic variations in drug metabolism may be influencing her response to treatment and decides to evaluate her medications based on their metabolic pathways, particularly acetylation, as individual variations in this process can alter drug effectiveness and toxicity. Which of the following drugs prescribed to this patient is not primarily metabolized by acetylation, potentially contributing to the ineffectiveness of her treatment?",
      "options": [
        {
          "label": "A",
          "text": "Hydrocortisone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Dapsone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Procainamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hydralazine",
          "correct": false
        }
      ],
      "correct_answer": "A. Hydrocortisone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Hydrocortisone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option B. Dapsone : An antibacterial commonly used in the treatment of leprosy and dermatological conditions , dapsone is metabolized by acetylation.</li><li>\u2022 Option B. Dapsone</li><li>\u2022 antibacterial</li><li>\u2022 used in the treatment of leprosy</li><li>\u2022 dermatological conditions</li><li>\u2022 Option C. Procainamide : An antiarrhythmic agent that is metabolized through acetylation . Variations in acetylation rates can affect its efficacy and side effect profile.</li><li>\u2022 Option C. Procainamide</li><li>\u2022 antiarrhythmic agent</li><li>\u2022 metabolized through acetylation</li><li>\u2022 Option D. Hydralazine : Used primarily for hypertension , hydralazine is metabolized through acetylation . Slow acetylators may have a higher risk of drug-induced lupus erythematosus.</li><li>\u2022 Option D. Hydralazine</li><li>\u2022 primarily for hypertension</li><li>\u2022 hydralazine is metabolized</li><li>\u2022 acetylation</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Hydrocortisone is not metabolized by acetylation , unlike other drugs such as dapsone , procainamide , and hydralazine , which can influence individual responses to drug therapy due to variations in acetylation rates .</li><li>\u27a4 Hydrocortisone</li><li>\u27a4 not metabolized by acetylation</li><li>\u27a4 drugs such as dapsone</li><li>\u27a4 procainamide</li><li>\u27a4 hydralazine</li><li>\u27a4 influence individual responses</li><li>\u27a4 drug therapy</li><li>\u27a4 acetylation rates</li><li>\u27a4 The drugs metabolized by acetylation include:</li><li>\u27a4 S: S ulfonamides (including Dapsone)</li><li>\u27a4 S: S</li><li>\u27a4 H: H ydralazine</li><li>\u27a4 H: H</li><li>\u27a4 I: I soniazid</li><li>\u27a4 I: I</li><li>\u27a4 P: P rocainamide</li><li>\u27a4 P: P</li><li>\u27a4 All these drugs can cause SLE like syndrome.</li><li>\u27a4 All these drugs can cause SLE like syndrome.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9958b127",
      "audio": ""
    },
    {
      "text": "In the provided drug response curve graph, what type of drug does the red-lined curve, represent?",
      "options": [
        {
          "label": "A",
          "text": "Partial agonist",
          "correct": false
        },
        {
          "label": "B",
          "text": "Full agonist",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inverse agonist",
          "correct": true
        },
        {
          "label": "D",
          "text": "Antagonist",
          "correct": false
        }
      ],
      "correct_answer": "C. Inverse agonist",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/29/whatsapp-image-2023-09-29-at-120333.jpeg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-165152.png"
      ],
      "explanation": "<p><strong>Ans. C) Inverse agonist</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A: Partial Agonist : This would produce a response , but its maximal effect is less than a full agonist , even when all receptors are occupied . The curve for a partial agonist would be above the baseline (indicating a positive response) but would not reach the same maximum as the full agonist.</li><li>\u2022 Option A: Partial Agonist</li><li>\u2022 produce a response</li><li>\u2022 maximal effect</li><li>\u2022 less than a full agonist</li><li>\u2022 receptors are occupied</li><li>\u2022 curve for a partial agonist</li><li>\u2022 above the baseline</li><li>\u2022 Option B: Full Agonist : This binds to the receptor and produces a maximum biological response. The curve would be expected to reach the highest point above the baseline in the graph, indicating the full efficacy of the drug.</li><li>\u2022 Option B: Full Agonist</li><li>\u2022 binds to the receptor</li><li>\u2022 produces a maximum biological response.</li><li>\u2022 Option D: Antagonist : An antagonist would not produce any response itself ; it would only block the effect of an agonist . The curve for a pure antagonist would be flat, aligning with the baseline because it does not activate the receptor nor produce a response on its own.</li><li>\u2022 Option D: Antagonist</li><li>\u2022 antagonist</li><li>\u2022 not produce any response itself</li><li>\u2022 block the effect of an agonist</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The red-lined curve that dips below the baseline represents an inverse agonist , which binds to a receptor and reduces its activity below the basal level .</li><li>\u27a4 red-lined curve</li><li>\u27a4 dips below the baseline</li><li>\u27a4 inverse agonist</li><li>\u27a4 receptor and reduces its activity below the basal level</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "608f1255",
      "audio": ""
    },
    {
      "text": "What does IP in the figure shown stands for:",
      "options": [
        {
          "label": "A",
          "text": "Drug is an instant release preparation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Meant for intra pulmonary use",
          "correct": false
        },
        {
          "label": "C",
          "text": "The standards according to Indian Pharmacopoeia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Drug tested preclinically via Intraperitoneal route",
          "correct": false
        }
      ],
      "correct_answer": "C. The standards according to Indian Pharmacopoeia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/24/10.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) The standards according to Indian Pharmacopoeia</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A : \"Instant release preparation\" refers to the formulation of the drug that affects how quickly it is released into the bloodstream; however, \"IP\" does not indicate this.</li><li>\u2022 Option A</li><li>\u2022 \"Instant release preparation\"</li><li>\u2022 formulation of the drug</li><li>\u2022 how quickly it is released into the bloodstream;</li><li>\u2022 Option B : \"Intra pulmonary use\" suggests that the drug is to be used within the lungs , typically inhalation drugs fall under this category, but \"IP\" does not denote this.</li><li>\u2022 Option B</li><li>\u2022 \"Intra pulmonary use\"</li><li>\u2022 drug is to be used within the lungs</li><li>\u2022 Option D : \"Intraperitoneal route \" is a method of drug administration used in research, but \"IP\" on a drug package does not relate to this.</li><li>\u2022 Option D</li><li>\u2022 \"Intraperitoneal route</li><li>\u2022 method of drug administration</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The \"IP\" on a medication package indicates that the drug conforms to the standards set by the Indian Pharmacopoeia.</li><li>\u27a4 \"IP\" on a medication package</li><li>\u27a4 drug conforms to the standards set by the Indian Pharmacopoeia.</li><li>\u27a4 IP stands for Indian Pharmacopoeia BP: British Pharmacopoeia USP: United Nations Pharmacopoeia BNF: British National Formulary</li><li>\u27a4 IP stands for Indian Pharmacopoeia</li><li>\u27a4 BP: British Pharmacopoeia</li><li>\u27a4 USP: United Nations Pharmacopoeia</li><li>\u27a4 BNF: British National Formulary</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b88e75e8",
      "audio": ""
    },
    {
      "text": "Which is the new \u03b23 agonist approved for overactive bladder?",
      "options": [
        {
          "label": "A",
          "text": "Fesoterodine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Trospium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mirabegron",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oxybutynin",
          "correct": false
        }
      ],
      "correct_answer": "C. Mirabegron",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Mirabegron</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Fesoterodine - Incorrect , it is an antimuscarinic agent used for overactive bladder but not a \u03b23 agonist.</li><li>\u2022 Option A. Fesoterodine</li><li>\u2022 Incorrect</li><li>\u2022 antimuscarinic agent</li><li>\u2022 overactive bladder</li><li>\u2022 not a \u03b23 agonist.</li><li>\u2022 Option B. Trospium - Incorrect , also an antimuscarinic , not a \u03b23 agonist .</li><li>\u2022 Option B. Trospium</li><li>\u2022 Incorrect</li><li>\u2022 antimuscarinic</li><li>\u2022 not a \u03b23 agonist</li><li>\u2022 Option D. Oxybutynin - Incorrect, this is an older antimuscarinic drug used for overactive bladder .</li><li>\u2022 Option D. Oxybutynin</li><li>\u2022 - Incorrect,</li><li>\u2022 older antimuscarinic drug</li><li>\u2022 overactive bladder</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Mirabegron is the first \u03b23 agonist approved for the treatment of overactive bladder, offering a mechanism of action different from antimuscarinic agents, and can be an option for patients who cannot tolerate or do not respond to anticholinergic medications.</li><li>\u2022 Mirabegron</li><li>\u2022 first \u03b23 agonist</li><li>\u2022 overactive bladder,</li><li>\u2022 mechanism of action different</li><li>\u2022 antimuscarinic agents,</li><li>\u2022 cannot tolerate</li><li>\u2022 do not respond to anticholinergic medications.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b710c98c",
      "audio": ""
    },
    {
      "text": "All of the following are contraindications to the use of atropine except?",
      "options": [
        {
          "label": "A",
          "text": "Benign hyperplasia of prostate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Angle closure glaucoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "AV block",
          "correct": true
        },
        {
          "label": "D",
          "text": "Paralytic ileus",
          "correct": false
        }
      ],
      "correct_answer": "C. AV block",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/11/40.jpg"
      ],
      "explanation": "<p><strong>Ans. C) AV block</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Benign hyperplasia of prostate: Atropine can cause urinary retention, which is why it is contraindicated in patients with benign prostatic hyperplasia (BPH). A tropine's antimuscarinic effects reduce bladder muscle contraction, exacerbating t he difficulty in urination caused by prostate enlargement.</li><li>\u2022 Option A. Benign hyperplasia of prostate: Atropine can cause urinary retention, which is why it is contraindicated in patients with benign prostatic hyperplasia (BPH). A tropine's antimuscarinic effects reduce bladder muscle contraction, exacerbating t he difficulty in urination caused by prostate enlargement.</li><li>\u2022 Option A. Benign hyperplasia of prostate:</li><li>\u2022 Atropine</li><li>\u2022 urinary retention,</li><li>\u2022 contraindicated in</li><li>\u2022 benign prostatic hyperplasia (BPH).</li><li>\u2022 tropine's antimuscarinic effects reduce bladder muscle contraction,</li><li>\u2022 exacerbating t</li><li>\u2022 urination</li><li>\u2022 prostate enlargement.</li><li>\u2022 Option B. Angle closure glaucoma: Atropine is contraindicated in patients with angle closure glaucoma because it can increase intraocular pressure . Its antimuscarinic action dilates the pupil (mydriasis), which can block the drainage of aqueous humor through the trabecular meshwork, worsening the condition.</li><li>\u2022 Option B. Angle closure glaucoma: Atropine is contraindicated in patients with angle closure glaucoma because it can increase intraocular pressure . Its antimuscarinic action dilates the pupil (mydriasis), which can block the drainage of aqueous humor through the trabecular meshwork, worsening the condition.</li><li>\u2022 Option B. Angle closure glaucoma:</li><li>\u2022 Atropine is contraindicated</li><li>\u2022 angle closure glaucoma</li><li>\u2022 increase intraocular pressure</li><li>\u2022 antimuscarinic action dilates the pupil (mydriasis),</li><li>\u2022 block the drainage of</li><li>\u2022 aqueous humor</li><li>\u2022 trabecular meshwork,</li><li>\u2022 Option D. Paralytic ileus: Atropine is contraindicated in patients with paralytic ileus because its antimuscarinic effects can inhibit gastrointestinal motility, exacerbating the condition by further slowing or stopping the movement of the intestines.</li><li>\u2022 Option D. Paralytic ileus: Atropine is contraindicated in patients with paralytic ileus because its antimuscarinic effects can inhibit gastrointestinal motility, exacerbating the condition by further slowing or stopping the movement of the intestines.</li><li>\u2022 Option D. Paralytic ileus:</li><li>\u2022 Atropine is contraindicated</li><li>\u2022 paralytic ileus</li><li>\u2022 antimuscarinic effects</li><li>\u2022 inhibit gastrointestinal motility, exacerbating</li><li>\u2022 slowing or stopping the movement</li><li>\u2022 intestines.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The objective is to identify the contraindications of atropine use, focusing on its antimuscarinic effects on various organ systems. Here is a table listing the contraindications of atropine along with explanations for each:</li><li>\u27a4 identify the contraindications of atropine</li><li>\u27a4 antimuscarinic effects</li><li>\u27a4 various organ systems.</li><li>\u27a4 contraindications of atropine</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e3848f85",
      "audio": ""
    },
    {
      "text": "Which of the following drug acts by stimulation of 5HT4 receptors?",
      "options": [
        {
          "label": "A",
          "text": "Buspirone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Renzapride",
          "correct": true
        },
        {
          "label": "C",
          "text": "Granisetron",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metoclopramide",
          "correct": false
        }
      ],
      "correct_answer": "B. Renzapride",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Renzapride</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Buspirone - It is a 5-HT1A agonist and is primarily used for the treatment of anxiety .</li><li>\u2022 Option A. Buspirone</li><li>\u2022 5-HT1A agonist</li><li>\u2022 primarily used for the treatment of anxiety</li><li>\u2022 Option C. Granisetron - This is a 5-HT3 receptor antagonist , which is indicated for the prevention of chemotherapy-induced nausea and vomiting .</li><li>\u2022 Option C. Granisetron -</li><li>\u2022 5-HT3 receptor antagonist</li><li>\u2022 indicated for the prevention of chemotherapy-induced nausea</li><li>\u2022 vomiting</li><li>\u2022 Option D. Metoclopramide - It is an antagonist at D2 receptors and is used for its anti-emetic and prokinetic properties .</li><li>\u2022 Option D. Metoclopramide</li><li>\u2022 antagonist at D2 receptors</li><li>\u2022 anti-emetic</li><li>\u2022 prokinetic properties</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Renzapride is a 5-HT4 receptor agonist used to increase peristalsis in the gastrointestinal tract . Many 5-HT4 agonists , useful for GERD , end in 'pride' such as cisapride , mosapride , and prucalopride . It's important to note that Tegaserod, another 5-HT4 agonist, was withdrawn due to increased risk of myocardial infarction.</li><li>\u2022 Renzapride is a 5-HT4 receptor agonist</li><li>\u2022 increase peristalsis in the gastrointestinal tract</li><li>\u2022 5-HT4 agonists</li><li>\u2022 GERD</li><li>\u2022 end in 'pride' such as cisapride</li><li>\u2022 mosapride</li><li>\u2022 prucalopride</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9aed9be",
      "audio": ""
    },
    {
      "text": "All the following drugs are used for treatment of congestive heart failure except:",
      "options": [
        {
          "label": "A",
          "text": "Nesiritide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sacubitril",
          "correct": false
        },
        {
          "label": "C",
          "text": "Trimetazidine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Metoprolol",
          "correct": false
        }
      ],
      "correct_answer": "C. Trimetazidine",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/screenshot-2024-05-08-094413.png"
      ],
      "explanation": "<p><strong>Ans. C) Trimetazidine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Nesiritide: Nesiritide is a recombinant B-type natriuretic peptide that has vasodilatory effects and is used in the management of acute decompensated heart failure.</li><li>\u2022 Option A. Nesiritide:</li><li>\u2022 recombinant B-type natriuretic peptide</li><li>\u2022 vasodilatory effects</li><li>\u2022 acute decompensated heart failure.</li><li>\u2022 Option B. Sacubitril: When combined with valsartan (a neprilysin inhibitor and an angiotensin II receptor blocker, respectively), sacubitril is used to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure.</li><li>\u2022 Option B. Sacubitril:</li><li>\u2022 combined with valsartan</li><li>\u2022 neprilysin inhibitor and an angiotensin II receptor blocker,</li><li>\u2022 reduce the risk of cardiovascular death</li><li>\u2022 hospitalization for heart failure in patients</li><li>\u2022 chronic heart</li><li>\u2022 failure.</li><li>\u2022 Option D. Metoprolol: Metoprolol is a beta-blocker that is used in the management of CHF. It reduces myocardial oxygen demand and can improve survival in patients with heart failure.</li><li>\u2022 Option D. Metoprolol:</li><li>\u2022 beta-blocker</li><li>\u2022 CHF.</li><li>\u2022 reduces myocardial oxygen demand</li><li>\u2022 improve survival in patients with heart failure.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "76a0acca",
      "audio": ""
    },
    {
      "text": "A new antiarrhythmic drug is found to be effective against both atrial and ventricular arrhythmias. Its effect on action potential is shown in the Figure. The effect of this new drug is most like:",
      "options": [
        {
          "label": "A",
          "text": "Lignocaine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Propanolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Encainide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Quinidine",
          "correct": true
        }
      ],
      "correct_answer": "D. Quinidine",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/25/image-2-min.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Quinidine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Lignocaine: Lignocaine (Lidocaine) is a Class IB antiarrhythmic drug that primarily works by shortening the action potential duration by blocking sodium channels , particularly in ischemic or depolarized cells . It does not prolong the action potential plateau.</li><li>\u2022 Option A. Lignocaine:</li><li>\u2022 Class IB antiarrhythmic drug</li><li>\u2022 shortening the action potential</li><li>\u2022 blocking sodium channels</li><li>\u2022 ischemic or depolarized cells</li><li>\u2022 does not</li><li>\u2022 action</li><li>\u2022 potential plateau.</li><li>\u2022 Option B. Propranolol: Propranolol is a Class II antiarrhythmic , which is a beta-blocker that reduces sympathetic nervous system activity. It does not have a direct effect on the action potential duration or plateau phase.</li><li>\u2022 Option B. Propranolol:</li><li>\u2022 Class II antiarrhythmic</li><li>\u2022 beta-blocker</li><li>\u2022 sympathetic nervous system</li><li>\u2022 activity.</li><li>\u2022 does not</li><li>\u2022 action potential duration or plateau phase.</li><li>\u2022 Option C. Encainide: Encainide , which is no longer widely used, was a Class IC antiarrhythmic drug that significantly slows conduction by blocking sodium channels but does not typically prolong the action potential duration.</li><li>\u2022 Option C. Encainide:</li><li>\u2022 Encainide</li><li>\u2022 no longer widely used,</li><li>\u2022 Class IC antiarrhythmic drug</li><li>\u2022 blocking sodium channels</li><li>\u2022 does not</li><li>\u2022 action potential duration.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to recognize the electrophysiologic effects of antiarrhythmic drugs on the cardiac action potential. Understanding how these drugs affect the action potential can provide insights into their therapeutic uses and potential arrhythmogenic risks. Quinidine's effect of prolonging the action potential duration is useful in the treatment of both atrial and ventricular arrhythmias, but it also carries the risk of proarrhythmia, underlining the need for careful patient selection and monitoring.</li><li>\u27a4 electrophysiologic effects of antiarrhythmic drugs</li><li>\u27a4 action potential</li><li>\u27a4 therapeutic uses and potential</li><li>\u27a4 arrhythmogenic risks. Quinidine's</li><li>\u27a4 prolonging the action potential duration</li><li>\u27a4 both atrial and</li><li>\u27a4 ventricular arrhythmias,</li><li>\u27a4 risk of proarrhythmia,</li><li>\u27a4 careful patient selection</li><li>\u27a4 monitoring.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9137afb0",
      "audio": ""
    },
    {
      "text": "A patient was taking verapamil for PSVT prophylaxis. He was given propranolol for treatment of essential tremors. This combination can result in:",
      "options": [
        {
          "label": "A",
          "text": "Atrial fibrillation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bradycardia with AV block",
          "correct": true
        },
        {
          "label": "C",
          "text": "Torsades de pointes",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tachycardia",
          "correct": false
        }
      ],
      "correct_answer": "B. Bradycardia with AV block",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Bradycardia with AV block</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Atrial fibrillation is not the most likely outcome of adding verapamil to propranolol therapy, although verapamil is sometimes used to control ventricular rate in patients with atrial fibrillation.</li><li>\u2022 Option A. Atrial fibrillation</li><li>\u2022 not</li><li>\u2022 outcome</li><li>\u2022 verapamil to propranolol</li><li>\u2022 verapamil is</li><li>\u2022 to control ventricular rate</li><li>\u2022 atrial fibrillation.</li><li>\u2022 Option C. Torsades\u2019 de pointes is a specific type of ventricular tachycardia often associated with a prolonged QT interval , which is not a typical side effect of either propranolol or verapamil.</li><li>\u2022 Option C. Torsades\u2019</li><li>\u2022 specific type of ventricular tachycardia</li><li>\u2022 prolonged QT interval</li><li>\u2022 not a typical side effect</li><li>\u2022 propranolol or verapamil.</li><li>\u2022 Option D. Tachycardia , or increased heart rate , would be unlikely as both drug s work to slow the heart rate.</li><li>\u2022 Option D. Tachycardia</li><li>\u2022 increased heart rate</li><li>\u2022 unlikely as both drug</li><li>\u2022 slow the heart rate.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objectives:</li><li>\u27a4 Therefore, the most appropriate answer in the context of this clinical scenario is B. Bradycardia with AV block, considering the pharmacological actions of both propranolol and verapamil and the symptoms reported by the patient.</li><li>\u27a4 B. Bradycardia</li><li>\u27a4 AV block,</li><li>\u27a4 pharmacological actions of both propranolol and verapamil</li><li>\u27a4 symptoms</li><li>\u27a4 Ref: KDT 8th/160</li><li>\u27a4 Ref: KDT 8th/160</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8d396a86",
      "audio": ""
    },
    {
      "text": "Which of the following thiazide diuretic is active even if the GFR is 30-40 ml/min?",
      "options": [
        {
          "label": "A",
          "text": "Metolazone",
          "correct": true
        },
        {
          "label": "B",
          "text": "Chlorothiazide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chlorthalidone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Benz thiazide",
          "correct": false
        }
      ],
      "correct_answer": "A. Metolazone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Metolazone</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Chlorothiazide : Chlorothiazide is a thiazide diuretic that is generally less effective in patients with significantly reduced GFR, as its effectiveness is diminished when the GFR falls below approximately 30-40 ml/min.</li><li>\u2022 Option B. Chlorothiazide</li><li>\u2022 Chlorothiazide</li><li>\u2022 thiazide diuretic</li><li>\u2022 less effective</li><li>\u2022 reduced</li><li>\u2022 GFR,</li><li>\u2022 diminished</li><li>\u2022 GFR falls below approximately 30-40 ml/min.</li><li>\u2022 Option C. Chlorthalidone : Chlorthalidone is another thiazide-like diuretic that is more effective than traditional thiazides in patients with higher GFRs but may not be as effective as metolazone in patients with severely reduced renal function.</li><li>\u2022 Option C. Chlorthalidone</li><li>\u2022 Chlorthalidone</li><li>\u2022 thiazide-like diuretic</li><li>\u2022 more effective than traditional thiazides</li><li>\u2022 higher GFRs</li><li>\u2022 not be as effective as metolazone</li><li>\u2022 severely reduced renal function.</li><li>\u2022 Option D. Benzthiazide : Similar to chlorothiazide and chlorthalidone, benzthiazide is a thiazide diuretic that typically requires a relatively normal renal function to be effective, and its efficacy may be reduced in patients with significant renal impairment.</li><li>\u2022 Option D. Benzthiazide</li><li>\u2022 chlorothiazide</li><li>\u2022 benzthiazide is a thiazide diuretic</li><li>\u2022 relatively normal renal function</li><li>\u2022 effective,</li><li>\u2022 its efficacy</li><li>\u2022 reduced in patients</li><li>\u2022 renal impairment.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational objective is to understand the importance of choosing the appropriate diuretic based on the patient's renal function. Metolazone is effective even in patients with reduced GFR, such as 30-40 ml/min , making it a valuable option for managing fluid retention in patients with chronic kidney disease or heart failure where other thiazide diuretics might be less effective. This highlights the need for careful selection of diuretics to ensure efficacy and avoid adverse outcomes in patients with varying degrees of renal function.</li><li>\u27a4 appropriate diuretic based on the patient's renal function.</li><li>\u27a4 Metolazone is effective</li><li>\u27a4 reduced GFR, such as 30-40 ml/min</li><li>\u27a4 fluid retention</li><li>\u27a4 chronic kidney disease or heart failure</li><li>\u27a4 other thiazide diuretics</li><li>\u27a4 less</li><li>\u27a4 effective.</li><li>\u27a4 highlights</li><li>\u27a4 careful selection of diuretics</li><li>\u27a4 avoid adverse</li><li>\u27a4 varying degrees of renal function.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8e45c8ec",
      "audio": ""
    },
    {
      "text": "Drug of choice for central diabetes Insipidus is. \u200b\u200b\u200b\u200b",
      "options": [
        {
          "label": "A",
          "text": "Desmopressin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Leuprolide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thiazide diuretics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Insulin",
          "correct": false
        }
      ],
      "correct_answer": "A. Desmopressin",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/01/picture1_dSWDtRK.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Desmopressin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B . Leuprolide : Leuprolide is a gonadotropin-releasing hormone (GnRH) agonist used in the treatment of hormone-sensitive conditions like prostate cancer, endometriosis, and uterine fibroids. It is not used in the treatment of diabetes insipidus as it does not influence ADH secretion or action.</li><li>\u2022 Option B</li><li>\u2022 Leuprolide</li><li>\u2022 gonadotropin-releasing hormone (GnRH) agonist</li><li>\u2022 hormone-sensitive</li><li>\u2022 prostate cancer, endometriosis, and uterine fibroids.</li><li>\u2022 not</li><li>\u2022 diabetes insipidus</li><li>\u2022 not</li><li>\u2022 ADH secretion or action.</li><li>\u2022 Option C . Thiazide Diuretics : Thiazide diuretics are used in the treatment of both nephrogenic diabetes insipidus (a form of the condition caused by the kidneys' inability to respond to ADH) as well as central (neurogenic) diabetes insipidus. They are drug of choice for nephrogenic diabetes insipidus but not central diabetes insipidus. Thiazides reduce urine volume in diabetes insipidus by increasing water absorption in the distal tubules of the kidney, but they do not address the lack of ADH production in central diabetes insipidus.</li><li>\u2022 Option C</li><li>\u2022 Thiazide Diuretics</li><li>\u2022 both nephrogenic diabetes insipidus</li><li>\u2022 kidneys' inability to respond to ADH)</li><li>\u2022 central (neurogenic) diabetes insipidus.</li><li>\u2022 choice for nephrogenic diabetes insipidus</li><li>\u2022 not central diabetes insipidus.</li><li>\u2022 reduce urine volume</li><li>\u2022 increasing water absorption in the distal tubules</li><li>\u2022 do not</li><li>\u2022 lack of ADH production in central</li><li>\u2022 diabetes insipidus.</li><li>\u2022 Option D . Insulin : Insulin is used in the treatment of diabetes mellitus, a completely different condition from diabetes insipidus. Diabetes mellitus involves problems with blood sugar control due to insufficient insulin production (Type 1 diabetes) or insulin resistance (Type 2 diabetes) . It does not directly affect the balance of water in the body, nor is it relevant to the treatment of diabetes insipidus.</li><li>\u2022 Option D</li><li>\u2022 Insulin</li><li>\u2022 treatment of diabetes mellitus,</li><li>\u2022 different</li><li>\u2022 from diabetes insipidus.</li><li>\u2022 Diabetes mellitus</li><li>\u2022 blood sugar control</li><li>\u2022 insufficient insulin production (Type 1 diabetes)</li><li>\u2022 insulin</li><li>\u2022 resistance (Type 2 diabetes)</li><li>\u2022 does not</li><li>\u2022 balance of water in the body, nor</li><li>\u2022 treatment</li><li>\u2022 diabetes insipidus.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "30ddb34b",
      "audio": ""
    },
    {
      "text": "Based on the mechanism shown in figure. Drug X is likely to be?",
      "options": [
        {
          "label": "A",
          "text": "Canagliflozin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Exenatide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pramlintide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vildagliptin",
          "correct": true
        }
      ],
      "correct_answer": "D. Vildagliptin",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture18.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Vildagliptin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Canagliflozin is incorrect because it is an SGLT-2 inhibitor, which promotes glucosuria by preventing glucose reabsorption in the renal tubules, which is unrelated to the DPP-4 inhibition pathway.</li><li>\u2022 Option A.</li><li>\u2022 Canagliflozin</li><li>\u2022 incorrect</li><li>\u2022 SGLT-2 inhibitor,</li><li>\u2022 glucosuria</li><li>\u2022 preventing glucose reabsorption</li><li>\u2022 in the renal tubules,</li><li>\u2022 Option B. Exenatide is incorrect because it is a GLP-1 analogu e that mimics the action of GLP-1 to stimulate insulin release but does not inhibit DPP-4.</li><li>\u2022 Option B.</li><li>\u2022 Exenatide</li><li>\u2022 incorrect</li><li>\u2022 GLP-1 analogu</li><li>\u2022 action of GLP-1 to stimulate insulin release</li><li>\u2022 Option C. Pramlintide is incorrect because it is an amylin analogue , which has a different mechanism of action involving the modulation of gastric emptying and promotion of satiety; it does not inhibit DPP-4.</li><li>\u2022 Option C.</li><li>\u2022 Pramlintide</li><li>\u2022 incorrect</li><li>\u2022 amylin analogue</li><li>\u2022 modulation of gastric emptying and promotion of satiety;</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vildagliptin is a DPP-4 inhibitor that enhances the action of incretins by preventing the breakdown of active GLP-1, leading to increased insulin release and decreased glucagon release , which helps to control blood glucose levels in diabetes mellitus.</li><li>\u27a4 Vildagliptin</li><li>\u27a4 DPP-4 inhibitor</li><li>\u27a4 incretins by preventing the breakdown of active GLP-1,</li><li>\u27a4 increased insulin release and decreased glucagon release</li><li>\u27a4 control blood glucose levels</li><li>\u27a4 diabetes mellitus.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "64d3dd11",
      "audio": ""
    },
    {
      "text": "The oral contraceptives shown in the figure are.",
      "options": [
        {
          "label": "A",
          "text": "Monophasic combined OCPs",
          "correct": true
        },
        {
          "label": "B",
          "text": "Biphasic combined OCPs",
          "correct": false
        },
        {
          "label": "C",
          "text": "Triphasic combined OCPs",
          "correct": false
        },
        {
          "label": "D",
          "text": "Emergency pills",
          "correct": false
        }
      ],
      "correct_answer": "A. Monophasic combined OCPs",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture19.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Monophasic combined OCPs</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Biphasic pills will have three colors. The first 10 tablets with less content of E+P, the next 11 tablets of different color containing higher amounts of hormones and last 7 tablets of different color that contain only iron.</li><li>\u2022 Option</li><li>\u2022 B. Biphasic pills will have three colors.</li><li>\u2022 first 10 tablets</li><li>\u2022 less content of E+P,</li><li>\u2022 11 tablets of different color</li><li>\u2022 higher amounts of hormones</li><li>\u2022 7 tablets of different color</li><li>\u2022 iron.</li><li>\u2022 Option C. Triphasic pills will have four colors. First 6 tablets, 6-10 tablets, 11-21 tablets and last 7 tablets of different color.</li><li>\u2022 Option</li><li>\u2022 C. Triphasic pills will have four colors.</li><li>\u2022 First 6 tablets, 6-10 tablets, 11-21 tablets and last 7 tablets</li><li>\u2022 different color.</li><li>\u2022 Option D. Emergency pills are incorrect because emergency contraception is not presented in a 28-day format but rather as a one-time dose or a short series of pills intended for immediate use after unprotected sex.</li><li>\u2022 Option</li><li>\u2022 D.</li><li>\u2022 Emergency pills</li><li>\u2022 incorrect</li><li>\u2022 emergency contraception</li><li>\u2022 not</li><li>\u2022 28-day</li><li>\u2022 one-time dose</li><li>\u2022 short series of pills</li><li>\u2022 immediate use after unprotected sex.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Monophasic combined OCPs consist of 21 active pills with a consistent dose of estrogen and progesterone , followed by 7 non-hormonal (iron) pills, and are represented in a pack with two colors\u201421 of one color and 7 of another, not to be confused with biphasic or triphasic pills which have varying hormone dosages and more color variation.</li><li>\u27a4 Monophasic combined OCPs</li><li>\u27a4 21 active pills</li><li>\u27a4 estrogen and progesterone</li><li>\u27a4 7 non-hormonal (iron) pills,</li><li>\u27a4 two colors\u201421 of one color</li><li>\u27a4 7 of another,</li><li>\u27a4 biphasic or triphasic pills</li><li>\u27a4 varying hormone dosages and more color variation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5910f57a",
      "audio": ""
    },
    {
      "text": "Which of the following medications is commonly used to promote abstinence in patients with alcohol use disorder?",
      "options": [
        {
          "label": "A",
          "text": "Acamprosate",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bupropion",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methadone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Naloxone",
          "correct": false
        }
      ],
      "correct_answer": "A. Acamprosate",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Acamprosate.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b98990c6",
      "audio": ""
    },
    {
      "text": "A patient with Parkinsonism developed this condition after treatment. Which of the following agents could be the causative agent?",
      "options": [
        {
          "label": "A",
          "text": "Levodopa",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amantadine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Trihexyphenidyl",
          "correct": false
        },
        {
          "label": "D",
          "text": "Selegiline",
          "correct": false
        }
      ],
      "correct_answer": "B. Amantadine",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture5.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Amantadine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Levodopa : While levodopa is the most effective medication for the management of Parkinson's disease symptoms, it is not commonly associated with skin changes like those depicted in the image.</li><li>\u2022 Option A. Levodopa</li><li>\u2022 most effective</li><li>\u2022 Parkinson's disease symptoms,</li><li>\u2022 not</li><li>\u2022 skin changes</li><li>\u2022 depicted in the image.</li><li>\u2022 Option C. Trihexyphenidyl : An anticholinergic drug used to treat Parkinsonism, but it is not typically linked with the skin condition shown.</li><li>\u2022 Option C. Trihexyphenidyl</li><li>\u2022 anticholinergic drug</li><li>\u2022 treat Parkinsonism,</li><li>\u2022 not</li><li>\u2022 linked with the skin condition</li><li>\u2022 shown.</li><li>\u2022 Option D.  Selegiline : An MAO-B inhibitor used to help control the symptoms of Parkinson's disease . It also does not commonly cause the skin changes seen in the image .</li><li>\u2022 Option D.  Selegiline</li><li>\u2022 MAO-B inhibitor</li><li>\u2022 symptoms of Parkinson's disease</li><li>\u2022 does not</li><li>\u2022 skin changes seen in the image</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to recognize the side effects associated with medications used in the treatment of Parkinson's disease . Amantadine can cause livedo reticularis , which is characterized by a purplish, mottled skin discoloration.</li><li>\u27a4 side effects</li><li>\u27a4 medications</li><li>\u27a4 treatment of Parkinson's disease</li><li>\u27a4 Amantadine</li><li>\u27a4 cause livedo reticularis</li><li>\u27a4 purplish, mottled skin discoloration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "206350fb",
      "audio": ""
    },
    {
      "text": "Which antiepileptic drug can cause this adverse effect?",
      "options": [
        {
          "label": "A",
          "text": "Carbamazepine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phenytoin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Phenobarbitone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Valproate",
          "correct": false
        }
      ],
      "correct_answer": "B. Phenytoin",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture7.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Phenytoin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Carbamazepine : While carbamazepine can have several side effects, it is not typically associated with gingival hyperplasia.</li><li>\u2022 Option A. Carbamazepine</li><li>\u2022 Option C. Phenobarbitone : Phenobarbitone (phenobarbital), another antiepileptic drug, also does not commonly cause gingival hyperplasia.</li><li>\u2022 Option C. Phenobarbitone</li><li>\u2022 Option D. Valproate : Valproate does not typically cause gingival hyperplasia as a side effect.</li><li>\u2022 Option D. Valproate</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational goal is to recognize the side effects associated with antiepileptic drugs, particularly phenytoin, which is known to cause gingival hyperplasia. Healthcare providers should monitor patients on phenytoin for this condition and educate them about maintaining good oral hygiene to help prevent or minimize this adverse effect.</li><li>\u27a4 Drugs causing gum hypertrophy are:</li><li>\u27a4 Drugs causing gum hypertrophy are:</li><li>\u27a4 Phenytoin Cyclosporine Calcium channel blockers like verapamil, diltiazem and nifedipine</li><li>\u27a4 Phenytoin</li><li>\u27a4 Cyclosporine</li><li>\u27a4 Calcium channel blockers like verapamil, diltiazem and nifedipine</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5a404a9b",
      "audio": ""
    },
    {
      "text": "A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received procaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?",
      "options": [
        {
          "label": "A",
          "text": "Benzocaine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chloroprocaine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cocaine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Mepivacaine",
          "correct": true
        }
      ],
      "correct_answer": "D. Mepivacaine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Mepivacaine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Benzocaine: Incorrect , as it is an ester local anesthetic like procaine.</li><li>\u2022 Option A. Benzocaine:</li><li>\u2022 Incorrect</li><li>\u2022 Option B. Chloroprocaine: Incorrect, another ester local anesthetic.</li><li>\u2022 Option B. Chloroprocaine:</li><li>\u2022 Incorrect,</li><li>\u2022 Option C. Cocaine: Incorrect , also an ester local anesthetic and has additional significant side effects.</li><li>\u2022 Option C. Cocaine:</li><li>\u2022 Incorrect</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients allergic to ester local anesthetics , amide local anesthetics lik e mepivacaine are preferred due to their different metabolic pathways , reducing the risk of allergic reactions.</li><li>\u27a4 allergic to ester local anesthetics</li><li>\u27a4 amide local anesthetics</li><li>\u27a4 e mepivacaine</li><li>\u27a4 metabolic pathways</li><li>\u27a4 reducing</li><li>\u27a4 allergic reactions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29465e4e",
      "audio": ""
    },
    {
      "text": "Which of the following anticoagulant therapy needs regular monitoring?",
      "options": [
        {
          "label": "A",
          "text": "Enoxaparin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Argatroban",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dabigatran",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fondaparinux",
          "correct": false
        }
      ],
      "correct_answer": "B. Argatroban",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/08/picture6.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Argatroban</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Enoxaparin: Enoxaparin is a low molecular weight heparin (LMWH) used for the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). While it has a mor e predictable dose-response relationship compared to unfractionated heparin , routine laboratory monitoring for anticoagulation effect is generally not required in most patients.</li><li>\u2022 Option A. Enoxaparin:</li><li>\u2022 low molecular weight heparin</li><li>\u2022 prevention and treatment of deep vein</li><li>\u2022 thrombosis (DVT) and pulmonary embolism (PE).</li><li>\u2022 mor</li><li>\u2022 dose-response</li><li>\u2022 unfractionated heparin</li><li>\u2022 laboratory monitoring</li><li>\u2022 not required in most patients.</li><li>\u2022 Option C. Dabigatran: Dabigatran is a direct oral anticoagulant (DOAC) that inhibits thrombin. It is used for stroke prevention in non-valvular atrial fibrillation and treatment of DVT and PE, among other indications. Dabigatran offers the advantage of fixed dosing without the need for routine coagulation monitoring.</li><li>\u2022 Option C. Dabigatran:</li><li>\u2022 direct oral anticoagulant (DOAC)</li><li>\u2022 inhibits thrombin.</li><li>\u2022 used</li><li>\u2022 stroke prevention</li><li>\u2022 non-valvular atrial fibrillation</li><li>\u2022 treatment of DVT</li><li>\u2022 PE,</li><li>\u2022 Dabigatran</li><li>\u2022 fixed dosing without</li><li>\u2022 routine coagulation monitoring.</li><li>\u2022 Option D. Fondaparinux: Fondaparinux is a synthetic pentasaccharide that inhibits factor Xa indirectly by binding to antithrombin . It is used for DVT prevention and treatment and for preventing PE. Like LMWH, fondaparinux generally does not require routine monitoring due to its predictable pharmacokinetic profile.</li><li>\u2022 Option D. Fondaparinux:</li><li>\u2022 synthetic pentasaccharide</li><li>\u2022 inhibits factor Xa indirectly</li><li>\u2022 binding to antithrombin</li><li>\u2022 DVT prevention and treatment</li><li>\u2022 preventing PE. Like LMWH, fondaparinux</li><li>\u2022 does not</li><li>\u2022 routine</li><li>\u2022 monitoring</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The educational objective is to understand which anticoagulant therapies require regular monitoring and which does not.</li><li>\u27a4 understand</li><li>\u27a4 anticoagulant therapies</li><li>\u27a4 regular monitoring</li><li>\u27a4 does not.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0742f303",
      "audio": ""
    },
    {
      "text": "A 34-year-old man with a long history of asthma is referred to pulmonologist. The physician decides to prescribe zileuton. The mechanism of action of this drug is to?",
      "options": [
        {
          "label": "A",
          "text": "Antagonize leukotriene D4 receptor.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inhibits 5-lipoxygenase.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Inhibit phosphodiesterase\u2019s.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stimulate beta 2 receptors.",
          "correct": false
        }
      ],
      "correct_answer": "B. Inhibits 5-lipoxygenase.",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Inhibits 5- lipoxygenase.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Antagonize leukotriene D4 receptor: This is the mechanism of leukotriene receptor antagonists like montelukast and zafirlukast, not zileuton.</li><li>\u2022 Option A. Antagonize leukotriene D4 receptor:</li><li>\u2022 leukotriene receptor antagonists like montelukast and</li><li>\u2022 zafirlukast,</li><li>\u2022 Option C. Inhibit phosphodiesterase: This is the action of drugs like theophylline, which are used as bronchodilators and anti-inflammatory agents but are unrelated to the mechanism of zileuton.</li><li>\u2022 Option C. Inhibit phosphodiesterase:</li><li>\u2022 action of drugs</li><li>\u2022 theophylline,</li><li>\u2022 bronchodilators</li><li>\u2022 anti-inflammatory agents</li><li>\u2022 Option D. Stimulate beta 2 receptors: This describes the action of beta-2 agonists such as salbutamol and terbutaline, which are used as rescue inhalers for acute asthma exacerbations.</li><li>\u2022 Option D. Stimulate beta 2 receptors:</li><li>\u2022 action of beta-2 agonists</li><li>\u2022 salbutamol and terbutaline,</li><li>\u2022 rescue inhalers for acute asthma exacerbations.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Zileuton's ability to inhibit the 5-lipoxygenase enzyme and thus decrease leukotriene production is vital for its effectiveness in asthma management, targeting a specific part of the inflammatory pathway.</li><li>\u27a4 Zileuton's ability</li><li>\u27a4 inhibit the 5-lipoxygenase enzyme</li><li>\u27a4 decrease leukotriene production</li><li>\u27a4 effectiveness in</li><li>\u27a4 asthma management,</li><li>\u27a4 targeting</li><li>\u27a4 inflammatory pathway.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d81cac1f",
      "audio": ""
    },
    {
      "text": "The mechanism of action of vancomycin is.",
      "options": [
        {
          "label": "A",
          "text": "Inhibition of cell wall synthesis",
          "correct": true
        },
        {
          "label": "B",
          "text": "Alteration of cell membrane integrity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Inhibition of protein synthesis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Inhibition of transcription",
          "correct": false
        }
      ],
      "correct_answer": "A. Inhibition of cell wall synthesis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Alteration of cell membrane integrity : Incorrect. Vancomycin's action is specific to cell wall synthesis and does not directly involve mechanisms that alter cell membrane integrity.</li><li>\u2022 Option</li><li>\u2022 B. Alteration of cell membrane integrity</li><li>\u2022 Incorrect.</li><li>\u2022 Vancomycin's</li><li>\u2022 cell wall synthesis</li><li>\u2022 does not</li><li>\u2022 alter cell membrane integrity.</li><li>\u2022 Option C. Inhibition of protein synthesis : Incorrect. Vancomycin does not interfere with protein synthesis; antibiotics such as tetracyclines and macrolides target this pathway.</li><li>\u2022 Option</li><li>\u2022 C. Inhibition of protein synthesis</li><li>\u2022 Incorrect.</li><li>\u2022 does not</li><li>\u2022 protein synthesis;</li><li>\u2022 tetracyclines and macrolides</li><li>\u2022 Option D. Inhibition of transcription : Incorrect. Vancomycin has no known effect on the transcription process within bacteria.</li><li>\u2022 Option</li><li>\u2022 D. Inhibition of transcription</li><li>\u2022 : Incorrect.</li><li>\u2022 no known effect</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Drugs inhibiting cell wall synthesis are:</li><li>\u27a4 Drugs inhibiting cell wall synthesis are:</li><li>\u27a4 F irmly: F osfomycin</li><li>\u27a4 F</li><li>\u27a4 F</li><li>\u27a4 B ind to: B eta lactams.</li><li>\u27a4 B</li><li>\u27a4 B</li><li>\u27a4 Bac terial: Bac itracin</li><li>\u27a4 Bac</li><li>\u27a4 Bac</li><li>\u27a4 C ell: C ycloserine</li><li>\u27a4 C</li><li>\u27a4 C</li><li>\u27a4 Va ll: Va ncomycin</li><li>\u27a4 Va</li><li>\u27a4 Va</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9b97d120",
      "audio": ""
    },
    {
      "text": "The process shown in figure is an important method of transfer of drug resistance in bacteria. This mechanism of horizontal transfer of drug resistance is known as? \u200b\u200b\u200b",
      "options": [
        {
          "label": "A",
          "text": "Conjugation",
          "correct": true
        },
        {
          "label": "B",
          "text": "Transduction",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transformation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Transposition",
          "correct": false
        }
      ],
      "correct_answer": "A. Conjugation",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/06/picture11.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Conjugation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Transduction: This is the transfer of genetic material between bacteria by a bacteriophage (a virus that infects bacteria ). If the genetic material contains a resistance gene , the bacterium can incorporate it into its genome and become resistant to the drug.</li><li>\u2022 Option B. Transduction:</li><li>\u2022 genetic material between bacteria by a bacteriophage</li><li>\u2022 infects bacteria</li><li>\u2022 genetic material contains a resistance gene</li><li>\u2022 its genome</li><li>\u2022 resistant to the drug.</li><li>\u2022 Option C. Transformation : This is the uptake of free DNA from the environment by a bacterial cell . If the DNA contains a resistance gene, the bacterium can incorporate it into its genome and become resistant to the drug . It is least common method of horizontal transfer of resistance.</li><li>\u2022 Option C. Transformation</li><li>\u2022 uptake of free DNA</li><li>\u2022 bacterial cell</li><li>\u2022 DNA contains</li><li>\u2022 resistance</li><li>\u2022 gene, the bacterium</li><li>\u2022 its genome</li><li>\u2022 resistant to the drug</li><li>\u2022 least common</li><li>\u2022 horizontal</li><li>\u2022 transfer of resistance.</li><li>\u2022 Option D. Transposition: This is the movement of a DNA sequence ( such as a resistance gene) from one location in the genome to another . Transposition occurs due to jumping genes called transposons.</li><li>\u2022 Option D. Transposition:</li><li>\u2022 movement of a DNA sequence (</li><li>\u2022 resistance gene)</li><li>\u2022 one location in the genome</li><li>\u2022 another</li><li>\u2022 jumping genes</li><li>\u2022 transposons.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Conjugation is a critical pathway for the horizontal transfer of genetic material, such as antibiotic resistance genes , between bacterial cells . This mode of genetic exchange plays a significant role in the spread of resistance in bacterial populations, highlighting the importance of understanding and monitoring antibiotic use to manage the risk of resistant infections.</li><li>\u27a4 Conjugation</li><li>\u27a4 horizontal transfer of genetic material,</li><li>\u27a4 antibiotic resistance genes</li><li>\u27a4 between</li><li>\u27a4 bacterial cells</li><li>\u27a4 mode of genetic exchange</li><li>\u27a4 spread of resistance in bacterial populations,</li><li>\u27a4 highlighting the importance of understanding</li><li>\u27a4 monitoring antibiotic</li><li>\u27a4 risk of resistant infections.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0948c58",
      "audio": ""
    },
    {
      "text": "A 65-year-old male presents with a cough, shortness of breath, and chest pain. Imaging studies reveal a mass in the lung, and a biopsy confirms the diagnosis of carcinoma lung. The patient has a history of chronic obstructive pulmonary disease (COPD) and bronchiectasis. He is currently on bronchodilators, inhaled corticosteroids, and oxygen therapy. The oncologist recommends chemotherapy for the treatment of the cancer. Which of the following drugs should be avoided in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Vinblastine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bleomycin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Mithramycin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Adriamycin",
          "correct": false
        }
      ],
      "correct_answer": "B. Bleomycin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Bleomycin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Vinblastine: While Vinblastine can have its own set of side effect s, including bone marrow suppression and neurotoxicity , it does not specifically exacerbate lung conditions like COPD or bronchiectasis, making it a safer option than Bleomycin.</li><li>\u2022 Option A. Vinblastine:</li><li>\u2022 side effect</li><li>\u2022 bone marrow suppression</li><li>\u2022 neurotoxicity</li><li>\u2022 does not</li><li>\u2022 exacerbate lung</li><li>\u2022 conditions</li><li>\u2022 COPD or bronchiectasis,</li><li>\u2022 safer</li><li>\u2022 Option C. Mithramycin: This drug is used in the treatment of testicular cancer and certain types of hypercalcemia but is less commonly associated with pulmonary complications, making it a potentially safer option for this patient.</li><li>\u2022 Option C. Mithramycin:</li><li>\u2022 testicular cancer</li><li>\u2022 certain types</li><li>\u2022 hypercalcemia</li><li>\u2022 less</li><li>\u2022 pulmonary complications,</li><li>\u2022 safer option</li><li>\u2022 Option D. Adriamycin (Doxorubicin): Adriamycin is known for its cardiotoxicity rather than pulmonary toxicity, and therefore, it does not pose the same specific risk to patients with pre-existing lung diseases as Bleomycin .</li><li>\u2022 Option D. Adriamycin (Doxorubicin):</li><li>\u2022 cardiotoxicity rather than pulmonary toxicity,</li><li>\u2022 does not pose</li><li>\u2022 risk to patients with pre-existing lung diseases as Bleomycin</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In patients with pre-existing lung conditions such as COPD and bronchiectasis, Bleomycin should be avoided due to its potential to cause significant pulmonary toxicity.</li><li>\u27a4 pre-existing lung</li><li>\u27a4 COPD and bronchiectasis, Bleomycin</li><li>\u27a4 avoided</li><li>\u27a4 potential to</li><li>\u27a4 pulmonary toxicity.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bb430962",
      "audio": ""
    },
    {
      "text": "A patient with head and neck cancer was given radiotherapy. After 6 months of radiotherapy, chemotherapy was started but patient presented with the clinical picture as shown after start of chemotherapy. What is the likely drug responsible for this?",
      "options": [
        {
          "label": "A",
          "text": "Doxorubicin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Carboplatin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cetuximab",
          "correct": false
        }
      ],
      "correct_answer": "A. Doxorubicin",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/405.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Doxorubicin</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Carboplatin: While Carboplatin can have a variety of side effects, it is less commonly associated with radiation recall syndrome.</li><li>\u2022 Option B. Carboplatin:</li><li>\u2022 Carboplatin</li><li>\u2022 variety of side effects,</li><li>\u2022 less</li><li>\u2022 radiation recall</li><li>\u2022 syndrome.</li><li>\u2022 Option C. Methotrexate: Methotrexate can cause mucositis and skin reactions but is not typically associated with radiation recall.</li><li>\u2022 Option C. Methotrexate:</li><li>\u2022 Methotrexate</li><li>\u2022 mucositis and skin reactions</li><li>\u2022 not</li><li>\u2022 radiation recall.</li><li>\u2022 Option D. Cetuximab: Cetuximab , a monoclonal antibody targeting EGFR, is associated with skin reactions; however, it is not typically cited as a cause of radiation recall syndrome.</li><li>\u2022 Option D. Cetuximab:</li><li>\u2022 Cetuximab</li><li>\u2022 monoclonal antibody targeting EGFR,</li><li>\u2022 skin reactions;</li><li>\u2022 not</li><li>\u2022 typically</li><li>\u2022 cause of radiation recall syndrome.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The most common drugs associated with RRS are anthracyclines (such a s doxorubicin ), taxanes (such as paclitaxel ), and gemcitabine.</li><li>\u27a4 The most common drugs associated with RRS are anthracyclines (such a s doxorubicin ), taxanes (such as paclitaxel ), and gemcitabine.</li><li>\u27a4 most common drugs</li><li>\u27a4 RRS are anthracyclines</li><li>\u27a4 s doxorubicin</li><li>\u27a4 taxanes</li><li>\u27a4 paclitaxel</li><li>\u27a4 gemcitabine.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b71c1ccf",
      "audio": ""
    },
    {
      "text": "A young female has presented to the OPD with burning sensation during urination, increased frequency and urgency. Which of the following fluoroquinolones is unlikely to be effective in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Ofloxacin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ciprofloxacin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pefloxacin",
          "correct": true
        },
        {
          "label": "D",
          "text": "Levofloxacin",
          "correct": false
        }
      ],
      "correct_answer": "C. Pefloxacin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pefloxacin</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "879fc92d",
      "audio": ""
    },
    {
      "text": "A 62-year-old male patient on anti-cancer therapy for prostate carcinoma presents with sore throat. The hemogram was ordered which shows the following values: Hb: 13 g/dL TLC: 2000/mm 3. RBC count: 5 million cells/microL Platelet count: 2,50,000 cells/microL If the condition is assumed to be due to anticancer drugs, which of the following drug is most likely to be effective in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Romiplostim",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oprelvekin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Peg-filgrastim",
          "correct": true
        },
        {
          "label": "D",
          "text": "Darbopoietin",
          "correct": false
        }
      ],
      "correct_answer": "C. Peg-filgrastim",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Peg-filgrastim</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f879c8c3",
      "audio": ""
    },
    {
      "text": "Propranolol should be avoided in all of the following conditions except?",
      "options": [
        {
          "label": "A",
          "text": "Hyperthyroidism",
          "correct": true
        },
        {
          "label": "B",
          "text": "Bradycardia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diabetes mellitus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bronchial asthma",
          "correct": false
        }
      ],
      "correct_answer": "A. Hyperthyroidism",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Hyperthyroidism</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "07728bf3",
      "audio": ""
    },
    {
      "text": "All of the listed medications are classified as a selective estrogen receptor modulators (SERM) except?",
      "options": [
        {
          "label": "A",
          "text": "Tamoxifen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clomiphene citrate",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mifepristone",
          "correct": true
        },
        {
          "label": "D",
          "text": "Raloxifene",
          "correct": false
        }
      ],
      "correct_answer": "C. Mifepristone",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Mifepristone</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "240ff1ec",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents with a unilateral throbbing headache associated with nausea and vomiting. She reports that she had multiple episodes in the past and her headache lasts for 1-2 days. She also says that her headache is aggravated by bright light and is relieved when she sits in a dark room. Which of the following drugs can be used to prevent these episodes?",
      "options": [
        {
          "label": "A",
          "text": "5HT 1B/1D agonists like Sumatriptan",
          "correct": false
        },
        {
          "label": "B",
          "text": "Beta blocker like Propranolol",
          "correct": true
        },
        {
          "label": "C",
          "text": "NSAIDs like diclofenac",
          "correct": false
        },
        {
          "label": "D",
          "text": "SSRIs like Fluoxetine",
          "correct": false
        }
      ],
      "correct_answer": "B. Beta blocker like Propranolol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Beta blocker like Propranolol</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4963d471",
      "audio": ""
    },
    {
      "text": "A farmer presents to the emergency department with pinpoint pupil, diarrhea, sweating, excessive lacrimation, salivation and muscle weakness. On examination there is bradycardia, BP is 80/60 mm Hg, pulse rate is 56/min and his plasma cholinesterase level was 52 U/mL. Which of the following drug can be effective for reversing the muscle weakness seen in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Neostigmine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Atropine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pralidoxime",
          "correct": true
        },
        {
          "label": "D",
          "text": "Edrophonium",
          "correct": false
        }
      ],
      "correct_answer": "C. Pralidoxime",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pralidoxime</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1c19f69",
      "audio": ""
    },
    {
      "text": "A man had just returned from Assam when he developed fever, chills and rigors. The peripheral smear demonstrated the presence of Plasmodium falciparum. What is the treatment of choice for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Oral Chloroquine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral artemether plus lumefantrine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Intravenous Artesunate",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oral artesunate with sulfadoxine-pyrimethamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Oral artemether plus lumefantrine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Oral artemether plus lumefantrine</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6b180b42",
      "audio": ""
    },
    {
      "text": "All of the following statements are true about the given dose-response curve EXCEPT?",
      "options": [
        {
          "label": "A",
          "text": "Drug B is the more efficacious than drug A",
          "correct": true
        },
        {
          "label": "B",
          "text": "Drug B is the most potent drug",
          "correct": false
        },
        {
          "label": "C",
          "text": "Drug C is more potent than Drug D",
          "correct": false
        },
        {
          "label": "D",
          "text": "Drug A is more potent than Drug C",
          "correct": false
        }
      ],
      "correct_answer": "A. Drug B is the more efficacious than drug A",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-171157.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Drug B is the more efficacious than drug A</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c165afed",
      "audio": ""
    },
    {
      "text": "A 35-year-old male went to Leh-Ladakh. He developed shortness of breath. Which of the following drug can be used to prevent mountain sickness at high altitude?",
      "options": [
        {
          "label": "A",
          "text": "Transdermal patch of scopolamine 12-24 hours before journey",
          "correct": false
        },
        {
          "label": "B",
          "text": "Oral scopolamine 30 minutes before journey",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral acetazolamide starting 2-3 days before reaching the hilly area",
          "correct": true
        },
        {
          "label": "D",
          "text": "Intravenous dexamethasone",
          "correct": false
        }
      ],
      "correct_answer": "C. Oral acetazolamide starting 2-3 days before reaching the hilly area",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Oral acetazolamide starting 2-3 days before reaching the hilly area</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "947b4668",
      "audio": ""
    },
    {
      "text": "A 9 young boy was brought to hospital with complaints of few episodes of fast blinking and staring at something for around 20 seconds. EEG shows spike and wave pattern. Which of the following drug should be used for treatment?",
      "options": [
        {
          "label": "A",
          "text": "Phenytoin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ethosuximide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Diazepam",
          "correct": false
        },
        {
          "label": "D",
          "text": "Carbamazepine",
          "correct": false
        }
      ],
      "correct_answer": "B. Ethosuximide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Ethosuximide</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a91b1c5f",
      "audio": ""
    },
    {
      "text": "A 43-year-old patient has developed tuberculosis. On laboratory investigations, the mycobacterium is found to be resistant to rifampicin, isoniazid and levofloxacin but sensitive to pyrazinamide, ethambutol, streptomycin, Bedaquiline and linezolide. This tuberculosis is referred to as?",
      "options": [
        {
          "label": "A",
          "text": "Multi drug resistant TB",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rifampicin resistant TB",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pre- Extensive drug resistant TB",
          "correct": true
        },
        {
          "label": "D",
          "text": "Extensive drug resistant TB",
          "correct": false
        }
      ],
      "correct_answer": "C. Pre- Extensive drug resistant TB",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-171927.png"
      ],
      "explanation": "<p><strong>Ans. C) Pre-Extensive drug resistant TB</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9b37a917",
      "audio": ""
    },
    {
      "text": "A patient who has just recovered from COVID-19 infection visits your OPD with black discoloration material in nose and posterior part of buccal cavity. He also gives history of using high dose steroid therapy during his treatment of COVID-19. Which of the following is most suitable oral drug for treatment of this organism?",
      "options": [
        {
          "label": "A",
          "text": "Fluconazole",
          "correct": false
        },
        {
          "label": "B",
          "text": "Amphotericin B",
          "correct": false
        },
        {
          "label": "C",
          "text": "Itraconazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Posaconazole",
          "correct": true
        }
      ],
      "correct_answer": "D. Posaconazole",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Posaconazole</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f3826380",
      "audio": ""
    },
    {
      "text": "Which of the following drugs does not reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF)?",
      "options": [
        {
          "label": "A",
          "text": "Valsartan plus Sacubitril",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metoprolol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Telmisartan",
          "correct": false
        },
        {
          "label": "D",
          "text": "Furosemide",
          "correct": true
        }
      ],
      "correct_answer": "D. Furosemide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Furosemide</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "016c81b3",
      "audio": ""
    },
    {
      "text": "A 60-year-old male patient with the history of schizophrenia and on treatment for drug-induced Parkinsonism presents with complaints of constipation, blurred vision and dry mouth. Which of the following drugs may be responsible for the above symptoms?",
      "options": [
        {
          "label": "A",
          "text": "Haloperidol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pramipexole",
          "correct": false
        },
        {
          "label": "C",
          "text": "Benzhexol",
          "correct": true
        },
        {
          "label": "D",
          "text": "Levo-dopa plus carbidopa",
          "correct": false
        }
      ],
      "correct_answer": "C. Benzhexol",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Benzhexol</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0123ecd9",
      "audio": ""
    },
    {
      "text": "Which of the following drug acts at the site marked by arrow as shown in the diagram?",
      "options": [
        {
          "label": "A",
          "text": "Remikiren",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ramipril",
          "correct": false
        },
        {
          "label": "C",
          "text": "Repaglinide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rosiglitazone",
          "correct": false
        }
      ],
      "correct_answer": "A. Remikiren",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-172655.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Remikiren</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d6bdd154",
      "audio": ""
    },
    {
      "text": "Which of the following statements is most appropriate regarding mechanism of action of enoxaparin?",
      "options": [
        {
          "label": "A",
          "text": "It acts as a calcium chelator and reduces the availability of calcium in coagulation pathway",
          "correct": false
        },
        {
          "label": "B",
          "text": "It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation",
          "correct": true
        },
        {
          "label": "C",
          "text": "It acts as a Vitamin K inhibitor that leads to inhibition of activation of clotting factors 2,7,9 and 10",
          "correct": false
        },
        {
          "label": "D",
          "text": "It inhibits tissue plasminogen activator resulting in stoppage of conversion of plasminogen to plasmin",
          "correct": false
        }
      ],
      "correct_answer": "B. It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) It binds and activates anti-thrombin 3 that accelerates its interaction with thrombin and factor Xa resulting in their degradation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Enoxaparin, a low molecular weight heparin, functions by binding to and activating antithrombin III. This accelerates the inactivation of thrombin and Factor Xa, thereby inhibiting the coagulation cascade and preventing clot formation. Understanding the specific mechanisms of action of different anticoagulants is crucial for their appropriate clinical use and for managing patients effectively.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a32dff4a",
      "audio": ""
    },
    {
      "text": "Which of the following diuretic acts on the site Y shown in the figure?",
      "options": [
        {
          "label": "A",
          "text": "Furosemide",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hydrochlorothiazide",
          "correct": false
        },
        {
          "label": "C",
          "text": "Spironolactone",
          "correct": true
        },
        {
          "label": "D",
          "text": "Acetazolamide",
          "correct": false
        }
      ],
      "correct_answer": "C. Spironolactone",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-173120.png"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Spironolactone</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "28255f88",
      "audio": ""
    },
    {
      "text": "Which of the following drugs undergoes Hoffman\u2019s degradation?",
      "options": [
        {
          "label": "A",
          "text": "Atracurium",
          "correct": true
        },
        {
          "label": "B",
          "text": "Mivacurium",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pancuronium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vecuronium",
          "correct": false
        }
      ],
      "correct_answer": "A. Atracurium",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Atracurium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option B. Mivacurium: Mivacurium is metabolized by plasma cholinesterase, not through Hoffman's degradation.</li><li>\u2022 Option B. Mivacurium:</li><li>\u2022 Option C. Pancuronium: Pancuronium is primarily metabolized by the liver and excreted by the kidneys, not by Hoffman's degradation.</li><li>\u2022 Option C. Pancuronium:</li><li>\u2022 Option D. Vecuronium: Vecuronium is also metabolized by the liver and excreted by the kidneys, and does not undergo Hoffman\u2019s degradation.</li><li>\u2022 Option D. Vecuronium:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "34df600d",
      "audio": ""
    },
    {
      "text": "Which of the following adverse effects is least likely to be seen after few years of using risperidone therapy?",
      "options": [
        {
          "label": "A",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperprolactinemia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Diabetes insipidus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tardive dyskinesia",
          "correct": false
        }
      ],
      "correct_answer": "C. Diabetes insipidus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Diabetes insipidus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Obesity : Risperidone, like other atypical antipsychotics, is associated with weight gain, which can lead to obesity. This side effect is due to its impact on metabolism and appetite regulation, often seen with prolonged use.</li><li>\u2022 Option A. Obesity</li><li>\u2022 Option B. Hyperprolactinemia : Risperidone is known to cause an increase in prolactin levels because it blocks dopamine D2 receptors in the tuberoinfundibular pathway. This can lead to hyperprolactinemia, resulting in symptoms such as galactorrhea, gynecomastia, and menstrual disturbances.</li><li>\u2022 Option B. Hyperprolactinemia</li><li>\u2022 Option D. Tardive dyskinesia : Tardive dyskinesia is a serious and often irreversible side effect of long-term antipsychotic use, including risperidone. It involves involuntary, repetitive movements, especially of the face and tongue. While less common with atypical antipsychotics compared to typical ones, it is still a potential risk with prolonged therapy.</li><li>\u2022 Option D. Tardive dyskinesia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risperidone, an atypical antipsychotic, has several long-term adverse effects, including obesity, hyperprolactinemia, and tardive dyskinesia. However, diabetes insipidus is not associated with risperidone use, making it the least likely adverse effect after years of therapy. Understanding the potential long-term side effects of antipsychotic medications is essential for monitoring and managing patients effectively.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "017979a5",
      "audio": ""
    },
    {
      "text": "An HIV positive female is taking antiretroviral therapy and is well controlled. She has delivered a baby. What should be the initial treatment for the newborn to prevent vertical transmission?",
      "options": [
        {
          "label": "A",
          "text": "Nevirapine + Zidovudine for 6 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "Nevirapine for 6 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "Nevirapine + Zidovudine for 6 months",
          "correct": false
        },
        {
          "label": "D",
          "text": "Zidovudine for 6 months",
          "correct": false
        }
      ],
      "correct_answer": "B. Nevirapine for 6 weeks",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-174039.png"
      ],
      "explanation": "<p><strong>Ans. B) Nevirapine for 6 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Nevirapine + Zidovudine for 6 weeks : This regimen is typically recommended for infants whose mothers did not receive adequate ART during pregnancy or if the mother's viral load was not well controlled near delivery. In such cases, combination therapy provides broader coverage to reduce the risk of transmission.</li><li>\u2022 Option A. Nevirapine + Zidovudine for 6 weeks</li><li>\u2022 Option C. Nevirapine + Zidovudine for 6 months : Six months of combination therapy is excessive and not in line with standard guidelines. The recommended duration is typically 4 to 6 weeks for adequate prophylaxis.</li><li>\u2022 Option C. Nevirapine + Zidovudine for 6 months</li><li>\u2022 Option D. Zidovudine for 6 months : zidovudine for 6 months is not the standard prophylaxis for newborns when the mother is well-controlled on ART.</li><li>\u2022 Option D. Zidovudine for 6 months</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For newborns of HIV-positive mothers who are well-controlled on ART, the appropriate initial prophylaxis to prevent vertical transmission is Zidovudine for 6 weeks. This regimen is effective in reducing transmission risk when maternal viral load is suppressed. It's important to follow guidelines that consider the maternal ART status to ensure optimal care for the newborn.</li><li>\u27a4 Prevention of vertical transmission</li><li>\u27a4 Prevention of vertical transmission</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2cb9383",
      "audio": ""
    },
    {
      "text": "A female presented to your morning OPD on 11 th June 2024. She reported that she went to a club on 6 th June and after that she had unprotected sexual intercourse that night. She fears getting pregnant. What is the contraceptive of choice in this case?",
      "options": [
        {
          "label": "A",
          "text": "Combined oral contraceptives",
          "correct": false
        },
        {
          "label": "B",
          "text": "Levonorgestrel",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mifepristone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ulipristal",
          "correct": true
        }
      ],
      "correct_answer": "D. Ulipristal",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Ulipristal</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Combined oral contraceptives : Combined oral contraceptives (COCs) can be used for emergency contraception but they need to be taken within 72 hours (3 days) of unprotected intercourse to be effective, which is beyond the time frame in this case.</li><li>\u2022 Option A. Combined oral contraceptives</li><li>\u2022 Option B. Levonorgestrel : Levonorgestrel is another commonly used emergency contraceptive. However, it is most effective when taken within 72 hours (3 days) after unprotected sex.</li><li>\u2022 Option B. Levonorgestrel</li><li>\u2022 Option C. Mifepristone : Mifepristone can be effective in higher doses for emergency contraception. Further it needs to be taken within 72 hours of unprotected intercourse.</li><li>\u2022 Option C. Mifepristone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ulipristal is the preferred emergency contraceptive for use up to 120 hours (5 days) after unprotected intercourse. In cases where unprotected intercourse occurred more than 72 hours but less than 120 hours prior, Ulipristal is more effective than Levonorgestrel and other methods. Understanding the time frames and efficacy of different emergency contraceptives is crucial for providing appropriate care and advice to patients.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "099a67b5",
      "audio": ""
    },
    {
      "text": "Which of the following is an adverse effect that is associated with the use of amiodarone?",
      "options": [
        {
          "label": "A",
          "text": "Red man syndrome",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tachycardia",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gynaecomastia",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pulmonary fibrosis",
          "correct": true
        }
      ],
      "correct_answer": "D. Pulmonary fibrosis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Pulmonary fibrosis</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Red man syndrome : Red man syndrome is associated with the rapid infusion of vancomycin, an antibiotic, and not with amiodarone. It is characterized by flushing, rash, and sometimes hypotension due to histamine release.</li><li>\u2022 Option A. Red man syndrome</li><li>\u2022 Option B. Tachycardia : Tachycardia is not a typical adverse effect of amiodarone. In fact, amiodarone is used to treat tachyarrhythmias. Some antiarrhythmics can cause arrhythmias as a side effect (proarrhythmia), but amiodarone is more commonly associated with bradycardia (slow heart rate) rather than tachycardia.</li><li>\u2022 Option B. Tachycardia</li><li>\u2022 Option C. Gynaecomastia : Gynaecomastia, the development of breast tissue in men, is a side effect associated with certain medications, such as some anti-androgens and spironolactone. While amiodarone can cause a variety of endocrine disturbances, gynaecomastia is not a common adverse effect.</li><li>\u2022 Option C. Gynaecomastia</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Amiodarone is an effective antiarrhythmic drug but has a range of potential adverse effects, with pulmonary fibrosis being one of the most serious. It is essential for healthcare providers to monitor patients on amiodarone for signs of lung toxicity and other side effects, ensuring timely intervention to prevent severe complications.</li><li>\u27a4 Adverse Effects of Amiodarone can be remembered as:</li><li>\u27a4 Adverse Effects of Amiodarone can be remembered as:</li><li>\u27a4 Th e: Th yroid problems (Hyper or hypothyroidism)</li><li>\u27a4 Th</li><li>\u27a4 Th</li><li>\u27a4 Periphery of: Peripheral neuropathy</li><li>\u27a4 Periphery</li><li>\u27a4 Peripheral</li><li>\u27a4 My:                              My ocardial depression</li><li>\u27a4 My:                              My</li><li>\u27a4 Lung:                           Lung fibrosis</li><li>\u27a4 Lung:                           Lung</li><li>\u27a4 Liver and: Liver damage</li><li>\u27a4 Liver</li><li>\u27a4 Liver</li><li>\u27a4 Cornea is: Corneal deposits</li><li>\u27a4 Cornea</li><li>\u27a4 Corneal</li><li>\u27a4 Photosensitive:           Photosensitivity (Blue man syndrome)</li><li>\u27a4 Photosensitive:           Photosensitivity</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7182fcc5",
      "audio": ""
    },
    {
      "text": "A pregnant female (in first trimester) who is a known case of bronchial asthma presented to hospital with blood pressure of 160/100 mm Hg. Which of the following is the preferred drug for this patient?",
      "options": [
        {
          "label": "A",
          "text": "Oral Labetalol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Intravenous labetalol",
          "correct": false
        },
        {
          "label": "C",
          "text": "Oral methyl dopa",
          "correct": true
        },
        {
          "label": "D",
          "text": "Oral Telmisartan",
          "correct": false
        }
      ],
      "correct_answer": "C. Oral methyl dopa",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Oral methyl dopa</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Let's consider each option:</li><li>\u2022 Let's consider each option:</li><li>\u2022 Option A. Oral Labetalol: Labetalol is a beta-blocker with alpha-blocking activity. It is commonly used for hypertension in pregnancy. However, being a beta-blocker, it can potentially exacerbate bronchial asthma by causing bronchoconstriction.</li><li>\u2022 Option A.</li><li>\u2022 Oral Labetalol:</li><li>\u2022 Option B. Intravenous Labetalol: This would be used for more immediate control of severely elevated blood pressure, like in a hypertensive crisis. The same concerns regarding bronchial asthma apply as with oral labetalol.</li><li>\u2022 Option B.</li><li>\u2022 Intravenous Labetalol:</li><li>\u2022 Option D. Oral Telmisartan : Telmisartan is an angiotensin II receptor blocker (ARB) and is contraindicated in pregnancy due to the risk of fetal toxicity, including renal dysfunction, oligohydramnios, and skeletal abnormalities. ARBs and ACE inhibitors should be avoided in pregnant women.</li><li>\u2022 Option D. Oral Telmisartan</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When managing hypertension in pregnant women, especially in the first trimester, the safety of both the mother and the fetus is paramount. Methyldopa is the preferred antihypertensive due to its long-standing safety profile in pregnancy. Beta blockers like labetalol although safe in pregnancy but are contra-indicated in bronchial asthma.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "76b7c43c",
      "audio": ""
    },
    {
      "text": "A 40-year-old obese female presented with Schizophrenia. Which of the following antipsychotic drug causes maximum weight gain?",
      "options": [
        {
          "label": "A",
          "text": "Chlorpromazine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Clozapine",
          "correct": true
        },
        {
          "label": "C",
          "text": "Aripiprazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ziprasidone",
          "correct": false
        }
      ],
      "correct_answer": "B. Clozapine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Clozapine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Chlorpromazine : Chlorpromazine is a typical antipsychotic that can also cause weight gain, but it is generally considered less likely to cause as much weight gain as clozapine. Typical antipsychotics tend to have a different side effect profile compared to atypical antipsychotics.</li><li>\u2022 Option A. Chlorpromazine</li><li>\u2022 Option C. Aripiprazole : Aripiprazole is an atypical antipsychotic that is associated with a lower risk of weight gain compared to clozapine and some other atypical antipsychotics. It is often chosen for patients who are concerned about weight gain and metabolic side effects.</li><li>\u2022 Option C. Aripiprazole</li><li>\u2022 Option D. Ziprasidone : Ziprasidone is another atypical antipsychotic with a relatively low risk of weight gain. It is considered weight-neutral or associated with minimal weight gain, making it a suitable option for patients with concerns about obesity and metabolic issues.</li><li>\u2022 Option D. Ziprasidone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When selecting an antipsychotic medication for patients, especially those who are obese or have metabolic concerns, it is important to consider the potential for weight gain. Clozapine is associated with significant weight gain and may not be the best choice for patients who are already obese. Understanding the side effect profiles of antipsychotic medications helps in making informed decisions to optimize patient care and minimize adverse effects.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9e628047",
      "audio": ""
    },
    {
      "text": "A patient of Schizophrenia was started on antipsychotic drug haloperidol. Few hours later, he presented with torticollis and muscular dystonia. What is the next best step for the management of this patient?",
      "options": [
        {
          "label": "A",
          "text": "Increase dose of haloperidol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Change haloperidol to clozapine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Give fluphenzine instead of haloperidol",
          "correct": false
        },
        {
          "label": "D",
          "text": "Give promethazine",
          "correct": true
        }
      ],
      "correct_answer": "D. Give promethazine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Give promethazine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Now, let's assess each option:</li><li>\u2022 Now, let's assess each option:</li><li>\u2022 Option A. Increase dose of haloperidol: Increasing the dose of haloperidol is not the appropriate response when a patient develops extrapyramidal symptoms (EPS) such as torticollis and muscular dystonia. It can exacerbate these side effects.</li><li>\u2022 Option A.</li><li>\u2022 Increase dose of haloperidol:</li><li>\u2022 Option B. Change haloperidol to clozapine: Clozapine is an atypical antipsychotic that is less likely to cause EPS compared to typical antipsychotics like haloperidol. Switching to clozapine can be a reasonable option to manage EPS.</li><li>\u2022 Option B.</li><li>\u2022 Change haloperidol to clozapine:</li><li>\u2022 Option C. Give fluphenzine instead of haloperidol: Fluphenazine is another typical antipsychotic and is not expected to be significantly different from haloperidol in terms of causing EPS. Switching to fluphenazine may not effectively address the EPS.</li><li>\u2022 Option C.</li><li>\u2022 Give fluphenzine instead of haloperidol:</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "daa2d521",
      "audio": ""
    },
    {
      "text": "Which of the following is the preferred drug for treatment of breast cancer in a 43-year-old pre-menopausal female?",
      "options": [
        {
          "label": "A",
          "text": "Methotrexate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Raloxifene",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tamoxifen",
          "correct": true
        },
        {
          "label": "D",
          "text": "Anastrozole",
          "correct": false
        }
      ],
      "correct_answer": "C. Tamoxifen",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Tamoxifen</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Methotrexate : Methotrexate is a chemotherapeutic agent that inhibits dihydrofolate reductase, interfering with DNA synthesis and cell replication. While it is used in some chemotherapy regimens for breast cancer, it is not the preferred first-line treatment for hormone receptor-positive breast cancer in pre-menopausal women.</li><li>\u2022 Option A. Methotrexate</li><li>\u2022 Option B. Raloxifene : Raloxifene is another SERM that is used primarily for the prevention and treatment of osteoporosis in post-menopausal women and for the reduction of breast cancer risk in certain high-risk post-menopausal women. It is not typically used for the treatment of breast cancer in pre-menopausal women.</li><li>\u2022 Option B. Raloxifene</li><li>\u2022 Option D. Anastrozole : Anastrozole is an aromatase inhibitor that reduces estrogen production by inhibiting the enzyme aromatase, which converts androgens to estrogen. Aromatase inhibitors are generally more effective in post-menopausal women because they target peripheral estrogen production. In pre-menopausal women, ovarian estrogen production remains active, making aromatase inhibitors less effective unless combined with ovarian suppression.</li><li>\u2022 Option D. Anastrozole</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 For pre-menopausal women with hormone receptor-positive breast cancer, Tamoxifen is the preferred drug due to its effectiveness in blocking estrogen receptors and reducing the risk of cancer recurrence. Understanding the appropriate use of hormone therapies in breast cancer treatment is essential for optimizing patient outcomes and tailoring therapy to individual patient profiles.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "34d70b7c",
      "audio": ""
    },
    {
      "text": "A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and efavirenz 600 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?",
      "options": [
        {
          "label": "A",
          "text": "No dose adjustment is required",
          "correct": true
        },
        {
          "label": "B",
          "text": "Add tenofovir 150 mg in the morning",
          "correct": false
        },
        {
          "label": "C",
          "text": "Add lamivudine 300 mg in the morning",
          "correct": false
        },
        {
          "label": "D",
          "text": "Add dolutegravir 50 mg in the morning",
          "correct": false
        }
      ],
      "correct_answer": "A. No dose adjustment is required",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) No dose adjustment is required</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5af95e31",
      "audio": ""
    },
    {
      "text": "A chronic smoker was on nicotine replacement therapy and clonidine tablets for smoking de-addiction. He stopped taking clonidine tablets and now presents with a headache. What is the reason behind this condition?",
      "options": [
        {
          "label": "A",
          "text": "Postural hypotension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Alpha 2 receptor upregulation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rebound hypertension",
          "correct": true
        },
        {
          "label": "D",
          "text": "Alpha 2 Receptor hypersensitivity",
          "correct": false
        }
      ],
      "correct_answer": "C. Rebound hypertension",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Rebound hypertension</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Postural hypotension : Postural hypotension, or orthostatic hypotension, is a condition where there is a significant drop in blood pressure upon standing up. This condition typically causes dizziness or light headedness rather than headaches and is not directly related to the abrupt cessation of clonidine.</li><li>\u2022 Option A. Postural hypotension</li><li>\u2022 Option B. Alpha 2 receptor upregulation : Prolonged stimulation of Alpha-2 receptors can result in their downregulation (not upregulation). This leads to failure of brakes and excessive release of NA.</li><li>\u2022 Option B. Alpha 2 receptor upregulation</li><li>\u2022 Option D. Alpha 2 Receptor hypersensitivity : Hypersensitivity of post synaptic alpha-1 and beta-1 receptors is responsible for excessive effect of NA when clonidine is stopped. It results in rebound hypertension. So hypersensitivity of alpha 2 receptor is wrong statement.</li><li>\u2022 Option D. Alpha 2 Receptor hypersensitivity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Clonidine is an antihypertensive medication that, when abruptly discontinued, can lead to rebound hypertension due to a sudden increase in sympathetic activity. This can cause symptoms such as headaches, which the patient is experiencing. It is important to taper off clonidine gradually to prevent such adverse effects. Understanding the potential withdrawal effects of medications used in addiction treatment is crucial for preventing complications and ensuring patient safety.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "39623651",
      "audio": ""
    },
    {
      "text": "Which of the following is a PCSK9 inhibitor?",
      "options": [
        {
          "label": "A",
          "text": "Alirocumab",
          "correct": true
        },
        {
          "label": "B",
          "text": "Ezetimibe",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bempedoic acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clofibrate",
          "correct": false
        }
      ],
      "correct_answer": "A. Alirocumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Alirocumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option B. Ezetimibe : Ezetimibe works by inhibiting the absorption of cholesterol in the small intestine, which leads to a reduction in the total amount of cholesterol presented to the liver. It does not inhibit PCSK9.</li><li>\u2022 Option B. Ezetimibe</li><li>\u2022 Option C. Bempedoic Acid : Bempedoic acid is a relatively new cholesterol-lowering medication. It inhibits ATP citrate lyase, an enzyme involved in cholesterol synthesis, but it is not a PCSK9 inhibitor.</li><li>\u2022 Option C. Bempedoic Acid</li><li>\u2022 Option D. Clofibrate : Clofibrate is a fibrate used to lower lipid levels, particularly triglycerides. It works by activating peroxisome proliferator-activated receptors (PPARs) and does not inhibit PCSK9.</li><li>\u2022 Option D. Clofibrate</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d22e0a64",
      "audio": ""
    },
    {
      "text": "A 72-year-old patient with a confirmed diagnosis of severe Alzheimer's dementia has shown aversion and non-compliance to oral medications. The health care professional advised to go for a new treatment that is given intravenously once in a month only and can also target the underlying cause of Alzheimer\u2019s disease. Which of the following drug is being suggested by the healthcare provider?",
      "options": [
        {
          "label": "A",
          "text": "Memantine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aducanumab",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rivastigmine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Galantamine",
          "correct": false
        }
      ],
      "correct_answer": "B. Aducanumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Aducanumab is a monoclonal antibody that targets amyloid-beta plaques in the brain, which are thought to be a contributing factor in Alzheimer's disease. It is administered via intravenous (IV) infusion once a month. This aligns with the patient's need for a non-oral medication that can be given less frequently and targets the underlying cause of Alzheimer's disease, making it the drug being suggested by the healthcare provider.</li><li>\u2022 Explanation of Other Options:</li><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Memantine : Memantine is an oral medication used to treat moderate to severe Alzheimer's disease by modulating the activity of glutamate, a neurotransmitter involved in learning and memory. It does not target amyloid plaques and is not administered intravenously.</li><li>\u2022 Option A. Memantine</li><li>\u2022 Option C. Rivastigmine : Rivastigmine is an acetylcholinesterase inhibitor used to treat mild to moderate Alzheimer's disease. It can be administered orally or via a transdermal patch, but not intravenously. It also does not target amyloid plaques.</li><li>\u2022 Option C. Rivastigmine</li><li>\u2022 Option D. Galantamine : Galantamine is another acetylcholinesterase inhibitor used for mild to moderate Alzheimer's disease. It is available in oral formulations and does not target amyloid plaques. It is not administered intravenously.</li><li>\u2022 Option D. Galantamine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Aducanumab is the only treatment among the options provided that is given intravenously once a month and targets the underlying amyloid-beta plaques associated with Alzheimer's disease. This makes it suitable for patients who have difficulty with oral medications and require a treatment that addresses the pathophysiology of the disease.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "581b32f1",
      "audio": ""
    },
    {
      "text": "Which of the following drugs used in treatment of leprosy can result in hyperpigmentation?",
      "options": [
        {
          "label": "A",
          "text": "Dapsone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ofloxacin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rifampicin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clofazimine",
          "correct": true
        }
      ],
      "correct_answer": "D. Clofazimine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Clofazimine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 Option A. Dapsone:</li><li>\u2022 Option A. Dapsone:</li><li>\u2022 Dapsone is an antibiotic commonly used in the treatment of leprosy. While it has various side effects, hyperpigmentation is not typically associated with dapsone. Common side effects include hemolysis (especially in individuals with G6PD deficiency) and peripheral neuropathy.</li><li>\u2022 Dapsone is an antibiotic commonly used in the treatment of leprosy. While it has various side effects, hyperpigmentation is not typically associated with dapsone. Common side effects include hemolysis (especially in individuals with G6PD deficiency) and peripheral neuropathy.</li><li>\u2022 Option B. Ofloxacin:</li><li>\u2022 Option B. Ofloxacin:</li><li>\u2022 Ofloxacin is a fluoroquinolone antibiotic that can be used as part of alternative regimens for leprosy. Hyperpigmentation is not a known side effect of ofloxacin. Its common side effects include gastrointestinal disturbances and tendinitis.</li><li>\u2022 Ofloxacin is a fluoroquinolone antibiotic that can be used as part of alternative regimens for leprosy. Hyperpigmentation is not a known side effect of ofloxacin. Its common side effects include gastrointestinal disturbances and tendinitis.</li><li>\u2022 Option C. Rifampicin:</li><li>\u2022 Option C. Rifampicin:</li><li>\u2022 Rifampicin is another cornerstone drug in the treatment of leprosy. It can cause orange-red discoloration of body fluids (such as urine, sweat, and tears), but it does not typically cause hyperpigmentation of the skin.</li><li>\u2022 Rifampicin is another cornerstone drug in the treatment of leprosy. It can cause orange-red discoloration of body fluids (such as urine, sweat, and tears), but it does not typically cause hyperpigmentation of the skin.</li><li>\u2022 Option D. Clofazimine:</li><li>\u2022 Option D. Clofazimine:</li><li>\u2022 Clofazimine is known to cause hyperpigmentation of the skin. This drug is used in leprosy treatment for its anti-inflammatory properties and its ability to kill Mycobacterium leprae. Clofazimine can lead to a characteristic reddish-brown to black discoloration of the skin, which can be quite distressing to patients but is usually harmless.</li><li>\u2022 Clofazimine is known to cause hyperpigmentation of the skin. This drug is used in leprosy treatment for its anti-inflammatory properties and its ability to kill Mycobacterium leprae. Clofazimine can lead to a characteristic reddish-brown to black discoloration of the skin, which can be quite distressing to patients but is usually harmless.</li><li>\u2022 In this case, the patient's hyperpigmentation is most likely due to clofazimine. This side effect is well-documented and is a result of the drug accumulating in the skin.</li><li>\u2022 Ref: KDT 8 th /833</li><li>\u2022 Ref: KDT 8 th /833</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e28fb9ef",
      "audio": ""
    },
    {
      "text": "Which of the following is an adverse effect with the long-term use of intermittent teriparatide for treatment of osteoporosis?",
      "options": [
        {
          "label": "A",
          "text": "Osteonecrosis of jaw bone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Osteosarcoma",
          "correct": true
        },
        {
          "label": "C",
          "text": "Subtrochantric fracture",
          "correct": false
        },
        {
          "label": "D",
          "text": "Loss of bone mass",
          "correct": false
        }
      ],
      "correct_answer": "B. Osteosarcoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Osteosarcoma</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In summary, the most significant potential adverse effect associated with the long-term use of teriparatide is the development of osteosarcoma, albeit this risk is based primarily on animal studies. Therefore, clinicians are advised to limit the duration of teriparatide therapy and monitor patients closely.</li><li>\u27a4 Ref: Goodman Gilman 13 th /899</li><li>\u27a4 Ref: Goodman Gilman 13 th /899</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bf076470",
      "audio": ""
    },
    {
      "text": "A 45-year-old patient with a known allergy to penicillin presents with a enterococcal endocarditis. The physician needs to prescribe an antibiotic but wants to ensure it is safe for a patient with a penicillin allergy. The patient has had previous allergic reactions to penicillin, including rash and swelling. Which of the following drugs can be used safely in a patient allergic to penicillin?",
      "options": [
        {
          "label": "A",
          "text": "Aztreonam",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vancomycin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ceftriaxone",
          "correct": false
        },
        {
          "label": "D",
          "text": "Piperacillin",
          "correct": false
        }
      ],
      "correct_answer": "B. Vancomycin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Vancomycin</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "938cf4ee",
      "audio": ""
    },
    {
      "text": "Which of the following drugs act as HER-2 inhibitor",
      "options": [
        {
          "label": "A",
          "text": "Cetuximab",
          "correct": false
        },
        {
          "label": "B",
          "text": "Necitumumab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pertuzumab",
          "correct": true
        },
        {
          "label": "D",
          "text": "Panitumumab",
          "correct": false
        }
      ],
      "correct_answer": "C. Pertuzumab",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Pertuzumab</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 HER-2 (Human Epidermal Growth Factor Receptor 2) overactivation is involved in pathogenesis of breast cancer. Trastuzumab and pertuzumab are monoclonal antibodies against her-2/neu and are used in treatment of breast cancer. Oral her-2 inhibitor drug is lapatinib.</li><li>\u2022 Let's review each of the listed drugs:</li><li>\u2022 Let's review each of the listed drugs:</li><li>\u2022 Option A. Cetuximab : Cetuximab is an EGFR (HER-1) inhibitor used primarily in the treatment of certain types of colorectal cancer and head and neck cancer.</li><li>\u2022 Option A.</li><li>\u2022 Cetuximab</li><li>\u2022 Option B. Necitumumab : Necitumumab is also an EGFR (HER-1) inhibitor, used in the treatment of metastatic squamous non-small cell lung cancer.</li><li>\u2022 Option B.</li><li>\u2022 Necitumumab</li><li>\u2022 Option C. Pertuzumab : Pertuzumab is a monoclonal antibody that targets HER-2 (Human Epidermal Growth Factor Receptor 2), not HER-1. It is used primarily in the treatment of HER-2 positive breast cancer.</li><li>\u2022 Option C.</li><li>\u2022 Pertuzumab</li><li>\u2022 Option D. Panitumumab : Panitumumab is an EGFR (HER-1) inhibitor, used in the treatment of metastatic colorectal cancer.</li><li>\u2022 Option D.</li><li>\u2022 Panitumumab</li><li>\u2022 Ref: KDT 8 th /930</li><li>\u2022 Ref: KDT 8 th /930</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "438ada16",
      "audio": ""
    },
    {
      "text": "A 60-year-old male patient underwent surgery under general anaesthesia. Rocuronium was used as a muscle relaxant during the procedure. After the surgery, the patient has not regained muscle function, indicating prolonged muscle paralysis. The medical team needs to reverse the effects of rocuronium quickly to ensure patient safety and recovery. Which of the following can result in the fastest reversal?",
      "options": [
        {
          "label": "A",
          "text": "Sugammadex",
          "correct": true
        },
        {
          "label": "B",
          "text": "Neostigmine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Edrophonium",
          "correct": false
        },
        {
          "label": "D",
          "text": "Atropine",
          "correct": false
        }
      ],
      "correct_answer": "A. Sugammadex",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Sugammadex</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Options:</li><li>\u2022 Option A. Sugammadex :</li><li>\u2022 Option A.</li><li>\u2022 Sugammadex</li><li>\u2022 Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.</li><li>\u2022 Sugammadex is a specific reversal agent for aminosteroid neuromuscular blocking agents such as rocuronium and vecuronium. It works by encapsulating the rocuronium molecules, rendering them inactive, and thus rapidly reversing the neuromuscular blockade. Sugammadex provides the fastest and most effective reversal of rocuronium-induced paralysis.</li><li>\u2022 Option B. Neostigmine :</li><li>\u2022 Option B.</li><li>\u2022 Neostigmine</li><li>\u2022 Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.</li><li>\u2022 Neostigmine is an acetylcholinesterase inhibitor that increases the levels of acetylcholine at the neuromuscular junction, competing with rocuronium. While effective, it is slower and less specific than sugammadex and can have more side effects.</li><li>\u2022 Option C. Edrophonium :</li><li>\u2022 Option C.</li><li>\u2022 Edrophonium</li><li>\u2022 Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.</li><li>\u2022 Edrophonium is also an acetylcholinesterase inhibitor but is less commonly used compared to neostigmine for reversing neuromuscular blockade. It is generally faster than neostigmine but still not as rapid or effective as sugammadex for rocuronium reversal.</li><li>\u2022 Option D. Atropine :</li><li>\u2022 Option D.</li><li>\u2022 Atropine</li><li>\u2022 Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.</li><li>\u2022 Atropine is not used for reversing neuromuscular blockade. It is an anticholinergic agent primarily used to counteract the muscarinic side effects of acetylcholinesterase inhibitors like neostigmine and edrophonium, such as bradycardia. It does not reverse muscle paralysis.</li><li>\u2022 In summary, sugammadex is the most effective and fastest-acting agent for reversing the effects of rocuronium, making it the best choice in this clinical scenario.</li><li>\u2022 Ref: KDT 8 th /381</li><li>\u2022 Ref: KDT 8 th /381</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "22ac7b5c",
      "audio": ""
    },
    {
      "text": "A 28-year-old pregnant woman at 32 weeks of gestation presents to the obstetric clinic with signs of preterm labor. The medical team decides to administer corticosteroids to promote fetal lung maturation and reduce the risk of neonatal respiratory distress syndrome. Choose the correct option that should be used for fetal lung maturation:",
      "options": [
        {
          "label": "A",
          "text": "Dexamethasone 12 mg 24 hourly 2 doses",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dexamethasone 6 mg 12 hourly 4 doses",
          "correct": true
        },
        {
          "label": "C",
          "text": "Betamethasone 12 mg 12 hourly 2 doses",
          "correct": false
        },
        {
          "label": "D",
          "text": "Betamethasone 12 mg 24 hourly 4 doses",
          "correct": false
        }
      ],
      "correct_answer": "B. Dexamethasone 6 mg 12 hourly 4 doses",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Dexamethasone 6 mg 12 hourly 4 doses</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c141ac73",
      "audio": ""
    },
    {
      "text": "Drug of choice for treatment of chemotherapy induced diarrhea is:",
      "options": [
        {
          "label": "A",
          "text": "Ondansetron",
          "correct": false
        },
        {
          "label": "B",
          "text": "Loperamide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pantoprazole",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dexamethasone",
          "correct": false
        }
      ],
      "correct_answer": "B. Loperamide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Loperamide</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. Ondansetron : Ondansetron is an antiemetic used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It works by blocking serotonin receptors in the brain and gut. While effective for nausea and vomiting, it is not used to treat diarrhea.</li><li>\u2022 Option A. Ondansetron</li><li>\u2022 Option C. Pantoprazole : Pantoprazole is a proton pump inhibitor (PPI) used to reduce stomach acid production and treat conditions like gastroesophageal reflux disease (GERD) and peptic ulcers. It is not indicated for the treatment of diarrhea.</li><li>\u2022 Option C. Pantoprazole</li><li>\u2022 Option D. Dexamethasone : Dexamethasone is a corticosteroid with anti-inflammatory and immunosuppressant properties. It is used in various conditions, including to reduce inflammation and manage chemotherapy-induced nausea and vomiting, but it is not the primary treatment for diarrhea.</li><li>\u2022 Option D. Dexamethasone</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Loperamide is the preferred medication for managing chemotherapy-induced diarrhea due to its effectiveness in slowing intestinal motility and allowing for better fluid absorption. Understanding the appropriate use of medications for specific side effects of chemotherapy is crucial for optimizing patient care and improving quality of life during treatment.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "74496ffb",
      "audio": ""
    },
    {
      "text": "Mechanism of action of antii-obesity drug, orlistat is?",
      "options": [
        {
          "label": "A",
          "text": "SGLT-2 inhibition",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lipase inhibition in GIT",
          "correct": true
        },
        {
          "label": "C",
          "text": "GLP-1 receptor agonism",
          "correct": false
        },
        {
          "label": "D",
          "text": "5HT2c receptor agonism",
          "correct": false
        }
      ],
      "correct_answer": "B. Lipase inhibition in GIT",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Lipase inhibition in GIT</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation of Other Options:</li><li>\u2022 Option A. SGLT-2 inhibition: SGLT-2 inhibitors (Sodium-glucose co-transporter-2 inhibitors) work by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This mechanism is primarily used in the management of type 2 diabetes to lower blood sugar levels and has an indirect effect on weight loss due to the loss of calories through urine, but it is not the mechanism of action of orlistat.</li><li>\u2022 Option A. SGLT-2 inhibition:</li><li>\u2022 Option C. GLP-1 receptor agonism: GLP-1 (Glucagon-like peptide-1) receptor agonists mimic the action of the incretin hormone GLP-1, which increases insulin secretion, suppresses glucagon secretion, and slows gastric emptying. These effects help reduce blood sugar levels and also contribute to weight loss. Drugs like liraglutide and exenatide fall into this category, but this is not the mechanism by which orlistat works.</li><li>\u2022 Option C. GLP-1 receptor agonism:</li><li>\u2022 Option D. 5HT2c receptor agonism: 5HT2c receptor agonists, such as lorcaserin, act on serotonin receptors in the brain, promoting a feeling of satiety and reducing appetite. By affecting the central nervous system, they help decrease food intake, leading to weight loss. However, orlistat does not work through this mechanism.</li><li>\u2022 Option D. 5HT2c receptor agonism:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Orlistat is an anti-obesity drug that functions by inhibiting gastric and pancreatic lipases, enzymes necessary for the breakdown and absorption of dietary fats. This inhibition results in the excretion of unabsorbed fat, thus reducing caloric intake and promoting weight loss. Understanding the specific mechanisms of action for various weight loss medications is crucial for selecting the appropriate treatment based on individual patient needs and conditions.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "300d7b31",
      "audio": ""
    },
    {
      "text": "A 55-year-old female presented to oncologist with breast lump. On examination and investigations, breast cancer was diagnosed. Echocardiography of the patient shows ejection fraction of 25%. Which of the following drug will you avoid in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Daunorubicin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Irinotecan",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cyclophosphamide",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methotrexate",
          "correct": false
        }
      ],
      "correct_answer": "A. Daunorubicin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Daunorubicin</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b82286bc",
      "audio": ""
    }
  ]
}